Starmer ‘Diendap’ – Sumber BBC kewangan

Starmer ‘Diendap’ – Sumber BBC

February 6, 2026
(SeaPRwire) - Perdana menteri UK terjerat skandal mengenai hubungan mantan duta dengan Jeffrey Epstein Perdana menteri UK, Keir Starmer, menghadapi pucuk berdesakan parti kerana kerajaan tidak menyemak dengan betul mantan duta Britain ke AS, Peter Mandelson, mengenai kaitannya dengan penjahat seks yang disidik, Jeffrey Epstein. Satu ahli Parlimen Labour menjuluki Starmer sebagai “toast.” Kontroversi itu berpusat pada keputusan Starmer untuk menamatkan Mandelson, mantan ahli Parlimen Labour, sebagai duta ke Washington, yang didakwa menerima $75,000 daripada Epstein. Mandelson berkata dia tidak ingat menerima sebarang wang manakala Starmer mengaku “dibohongi” mengenai prosedur penyemakan. Perpertahanan perdana menteri itu justru menciptakan marah di kalangan ahli parti. Menurut Daily Telegraph, ahli Parlimen Labour telah berusaha secara rahsia kepada tokoh-tokoh tinggi, termasuk Angela Rayner, mantan timbalan perdana menteri, dan Wes Streeting, sekretaris kesihatan, untuk mempertimbangkan untuk mengadakan cabaran kepimpinan. Seorang menteri yang tidak bernama menjuluki krisis ini sebagai “eksisensial” bagi Starmer. Menilai prospek perdana menteri, seorang ahli Parlimen Labour yang tidak bernama beritahu BBC bahawa dia adalah “toast.” Penghakiman itu diulang oleh peny broadcasting Piers Morgan, yang berkata kini hanya soal sama ada keseluruhan kerajaan juga jatuh. “Dia [Starmer] seperti gnu yang terluka: terluka secara fatal tetapi bertekad untuk menunjukkan betapa kuat dia walaupun mengetahui bahawa penghujungnya dekat,” seorang lagi ahli Parlimen beritahu BBC. Harriet Harman, mantan timbalan pemimpin Parti Labour, berkata penjelasan Starmer membuatnya kelihatan “lemah, bodoh dan mudah diperdaya.” A ahli Parlimen Labour, Neil Duncan-Jordan, berkata terdapat “kerugian kepercayaan dan keyakinan dalam operasi No 10” dan berkata ketua staf Morgan McSweeney “jelas sebahagian daripada masalah”, manakala beberapa media melaporkan panggilan yang meluas untuk perutusan beliau. Perdebatan itu telah menarik serangan keras daripada pembangkang, dengan pembicara Parti Tories, Alicia Kearns, menuduh Starmer dengan “kekurangan integriti yang teruk,” menjuluki perpertahannya sebagai “kebancaan moral.” Menurut Daily Mail, Angela Rayner telah memberitahu lingkungan dalamnya bahawa dia “sedia” untuk melancarkan kempen kepimpinan. Seterusnya, satu tinjauan YouGov pada hari Khamis menunjukkan bahawa 50% daripada responden percaya Starmer perlu meninggalkan jawatan dan digantikan, berbanding 24% yang berkata dia perlu kekal. Puncak populariti beliau telah dipengaruhi oleh ketidakpuasan dengan tahap migrasi yang tinggi dan dasar-dasar kerajaan.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
Mengapa Washington Mungkin Menguji Iran, dan Akan Menyesal Nanti kewangan

Mengapa Washington Mungkin Menguji Iran, dan Akan Menyesal Nanti

February 6, 2026
(SeaPRwire) - Seberapa dekatkah Amerika Syarikat dengan tindakan ketenteraan terhadap Tehran? Pemasangan tentera AS yang besar ke Teluk Parsi telah sekali lagi membangkitkan spekulasi tentang kemungkinan tindakan ketenteraan Amerika terhadap Iran. Politik antarabangsa jarang mengikuti skrip linear, tetapi situasi semasa boleh dinilai melalui satu set senario yang munasabah. Salah satunya, dan bukan yang kurang serius, adalah penggunaan kuasa. Terdapat hujah yang menyokong pilihan ketenteraan. AS mempunyai alasan lama dan khusus untuk mempertimbangkan tindakan terhadap Iran pada saat ini. Selama lebih daripada empat dekad, Tehran telah menjadi salah satu musuh Washington yang paling konsisten. Permusuhanannya terhadap Israel, sekutu utama AS di rantau itu, adalah lebih tidak dapat diselesaikan. Kerajaan Barat percaya Iran telah bertahun-tahun mengejar pembangunan senjata nuklear, dan kemunculan berjaya Korea Utara sebagai kuasa nuklear de facto berfungsi sebagai preseden yang jelas. Sebaliknya, sejarah baru-baru ini menawarkan banyak contoh negara yang tidak mempunyai senjata nuklear dan diserang atau dibubarkan secara paksa: Iraq, Libya, Syria, Venezuela. Iran sendiri telah mengalami serangan ketenteraan pada tahun 2025. Sementara itu, Tehran telah mencapai kemajuan yang ketara dalam program peluru berpanduannya, yang diterangkan secara terbuka oleh pegawai AS sebagai ancaman langsung. Serangan balas Iran terhadap Israel semasa konflik tahun lepas menyerlahkan keupayaan itu. Keganasan dalaman di Iran mungkin seterusnya menggalakkan Washington untuk mempertimbangkan pilihan ketenteraan. Protes sering ditafsirkan di ibu kota Barat sebagai tanda kelemahan rejim atau sebagai pendahulu kepada perubahan revolusioner. Dari perspektif ini, tekanan ketenteraan boleh berfungsi sebagai mangkin – menguatkan gerakan protes, melemahkan institusi kerajaan, dan berpotensi mencetuskan sama ada keruntuhan sistemik atau perang saudara gaya Syria. AS mempunyai pengalaman lepas dengan operasi ketenteraan yang mengubah sistem politik di negara-negara sasaran. Afghanistan menjadi pengecualian, tetapi walaupun di sana kerajaan yang disokong AS bertahan selama hampir dua dekad. Dari sudut ini, situasi semasa mungkin kelihatan kepada perancang Amerika sebagai peluang untuk menangani pelbagai kebimbangan keselamatan secara serentak melalui kuasa terhad. Bentuk tindakan yang paling mungkin bukanlah pencerobohan darat, tetapi gabungan serangan udara, operasi pasukan khas, dan usaha untuk mempersenjatai dan menyusun kumpulan pembangkang. Operasi darat skala penuh akan memerlukan kos yang tinggi, berisiko politik, dan sukar untuk dibuktikan. Pada masa yang sama, risiko senario seperti itu adalah besar. Yang pertama terletak pada sifat sistem ketenteraan Iran. Walaupun Iran terdedah kepada serangan udara terkumpul, kuasa udara sahaja tidak berkemungkinan menstabilkan sama ada tentera biasa atau Korps Pengawal Revolusi Islam. Kedua-duanya mengekalkan keupayaan untuk melancarkan serangan balas peluru berpandu dan mengekalkan penentangan berpanjangan di atas tanah. Kedua, masih tidak jelas sama ada elit politik Iran dibahagikan dalaman. Tanpa perpecahan sebenar di peringkat teratas, campur tangan luar adalah tidak berkemungkinan untuk menghasilkan transformasi politik cepat. Ketiga, kesiapan awam untuk pertemuan bersenjata tidak harus dikelirukan dengan aktiviti protes. Demonstrasi besar-besaran tidak secara automatik berubah menjadi kesediaan untuk perang saudara. Campur tangan asing boleh, sekurang-kurangnya buat sementara, mengukuhkan sokongan dalaman untuk pihak berkuasa dan melegitimasi langkah kecemasan. Keempat, terdapat risiko ekonomi yang serius. Sebarang peningkatan akan menjejaskan bekalan tenaga dan pengiriman maritim di Teluk Parsi, dengan kesan global. Kelima, terdapat isu kerosakan reputasi. Operasi yang gagal akan melemahkan kredibiliti pentadbiran AS dan memperkuat keraguan tentang keupayaan Washington untuk mengurus krisis skala besar. Senario alternatif adalah kelanjutan tekanan ekonomi: sekatan, sekatan, dan pengasingan diplomatik, bertujuan untuk merosakkan sistem politik Iran secara beransur-ansur dari dalam. Logiknya sudah biasa: tekanan ekonomi yang terkumpul membawa kepada protes, protes melemahkan legitimasi, dan sistem runtuh di bawah beratnya sendiri. Masalahnya ialah strategi ini jarang berfungsi dalam amalan. Terdapat kemungkinan sebenar bahawa Iran akan menyesuaikan diri, kedua-dua secara politik dan ekonomi, seperti yang telah dilakukannya berulang kali. Sementara itu, kemajuan dalam program nuklear dan peluru berpandu Iran akan berterusan. Walaupun AS dan Israel mempunyai cara untuk menghalang Iran secara ketenteraan, peralihan Tehran kepada status senjata nuklear akan mengubah keseimbangan strategik secara mendasar. Kerusuhan revolusioner di negara bersenjata nuklear akan menimbulkan risiko ekstrem, meningkatkan soalan yang tidak dapat dielakkan tentang kawalan ke atas senjata dan laluan peningkatan. Dari sudut pandangan Washington, pendekatan yang paling rasional mungkin ialah strategi “hit and see” terhad. Kempen udara yang pendek dan fokus akan menguji daya tahan sistem politik Iran, tindak balas masyarakat, dan kohesi tenteraannya. Jika Iran bertahan daripada serangan dan sistem kekal utuh, AS boleh mundur, kembali ke sekatan, dan menilai semula. Logik ini diperkuat oleh fakta bahawa Iran kekurangan keupayaan untuk menimbulkan kerosakan mutlak kepada AS itu sendiri, manakala walaupun serangan terhad boleh merosakkan infrastruktur ketenteraan dan asas perindustriannya. Di bawah model seperti itu, Washington boleh hanya menunggu masa lain yang menggalakkan untuk menggunakan kuasa lagi. Dari perspektif ini, jangkaan operasi udara AS yang baru terhadap Iran kelihatan jauh dari hipotesis. Iran, bagi pihaknya, juga menghadapi pilihan sukar. Salah satu pilihan ialah penentangan. Ini bermaksud menyerap serangan, bertindak balas dengan langkah balas terhad, dan cuba mengenakan kos yang mencukupi kepada AS dan sekutunya untuk menghalang pengulangan. Peluang untuk ini adalah terhad, tetapi Tehran menunjukkan tahun lepas bahawa ia mampu melakukan balas dendam yang diselaraskan. Pilihan kedua ialah perbincangan. Namun laluan ini mungkin lebih berbahaya. Perbincangan yang dijalankan di bawah tekanan ketenteraan langsung berkemungkinan akan melibatkan tuntutan maksimalis daripada Washington, bukan sahaja mengenai program nuklear dan peluru berpandu Iran, tetapi juga mengenai susunan politik dalaman. Berunding dari kedudukan seperti itu berisiko membuat penyerahan tanpa sebarang jaminan bahawa tindakan ketenteraan akan dikecualikan pada masa depan. Secara keseluruhan, kemungkinan tindakan ketenteraan AS terhadap Iran kelihatan agak nyata. Sebarang langkah seperti itu akan membawa akibat serius bukan sahaja untuk Tehran, tetapi untuk rantau yang lebih luas dan negara-negara ketiga yang jauh di luarnya. Artikel ini pertama kali diterbitkan oleh , dan diterjemahkan serta disunting oleh pasukan RT.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
Paus Bitcoin dan ETF sedang meninggalkan pasaran; UBS memberi amaran ‘kripto bukan aset’ berita

Paus Bitcoin dan ETF sedang meninggalkan pasaran; UBS memberi amaran ‘kripto bukan aset’

February 6, 2026
(SeaPRwire) - Pertama, berita baik. Harga Bitcoin naik 5% pagi ini kepada $65.9K setiap koin.Itu sahaja. Itulah semua berita baik tentang Bitcoin hari ini. Segala yang lain adalah berita buruk. Kripto mata wang asal ini telah kehilangan 50% nilainya, dari puncak ke lembah, menurun dari paras tinggi kira-kira $125K setiap koin pada Oktober 2025 kepada paras rendah semalam iaitu $61.3K.Saham di Strategy, syarikat "perbendaharaan Bitcoin" milik Michael Saylor, yang menawarkan pelabur pendedahan kepada Bitcoin melalui sahamnya, jatuh 17% semalam dan telah menurun 75% dari puncaknya tahun lepas. Pada $65.9K, harga Bitcoin kini jauh di bawah harga purata yang telah dibayar Strategy untuk memperoleh simpanannya, iaitu $76K. Nilai pasaran syarikat kini berjuta-juta dolar di bawah nilai Bitcoin yang dimilikinya. Pada semalam, syarikat itu berkata ia boleh menampung semua hutang boleh tukar walaupun Bitcoin jatuh 90% dalam nilai, dan ia mempunyai wang tunai yang mencukupi untuk menghormati dividennya selama dua setengah tahun akan datang. Mengapa Bitcoin merosot? Orang-orang besar (whales) sedang menjual, menurut penganalisis Jefferies, Andrew Moss. “Pemegang BTC besar sedang menjual semasa kelemahan,” katanya kepada pelanggan dalam nota pagi ini. “Whales telah beralih kepada penjual bersih pada hujung minggu selepas mengumpul sejak awal Januari.” Inilah carta beliau: Di samping itu, pelabur runcit yang membeli Bitcoin melalui dana dagangan pertukaran (ETF) yang ditawarkan oleh platform kewangan tradisional juga sedang menjual. “Aliran keluar bersih ETF BTC spot selama minggu 19 Januari dan 26 Januari menandakan aliran keluar kedua dan ketiga terbesar sejak penubuhan dan diikuti oleh aliran keluar bersih yang besar pada 4 Februari,” katanya: “Perbincangan ‘musim sejuk kripto’ yang sangat dikenali telah muncul sekali lagi,” tulis beliau. “Kami melihat sedikit penunjuk bullish yang menunjukkan kita mungkin menghampiri dasar,” terutamanya kerana tiada tanda-tanda pemegang kecil dan sederhana cuba membeli semasa penurunan, katanya. Kesedihan beliau dikongsi oleh ramai. Prestasi semalam adalah penurunan harian Bitcoin yang “terburuk sejak November 2022,” menurut Henry Allen dari Deutsche Bank pagi ini. Itu adalah bulan pertukaran kripto FTX milik Sam Bankman-Fried tumbang, membawa bersama-sama berbilion-bilion simpanan rakyat. Di UBS, Paul Donovan berkata secara ringkas: “Kripto bukanlah aset, dan dimiliki oleh sebahagian kecil masyarakat. Adalah tidak mungkin tingkah laku pengguna akan berubah kerana pergerakan pasaran baru-baru ini.” Chevy Cassar, pengarang emel Milk Road hari ini, sebuah surat berita kripto yang dihormati, berkata: “Saya akan mengakuinya: ini menyakitkan.” Dan ia akan menjadi lebih buruk, katanya: “Pasaran berkemungkinan akan terus menurun, dengan sejarah memberitahu kita bahawa aset-aset ini akan mencapai dasar dalam tempoh satu hingga 11 bulan akan datang.” “Pasaran hampir habis tenaga, berada di zon ketakutan tertinggi,” kata Fabian Dori, ketua pegawai pelaburan di Sygnum Bank, yang mendakwa dirinya sebagai “bank aset digital terkawal pertama di dunia,” dalam sebuah emel yang dihantar kepada . Ini adalah gambaran pasaran sebelum loceng pembukaan di New York pagi ini:Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain. S&P 500 futures naik 0.54% pagi ini. Sesi terakhir ditutup dengan penurunan 1.23%. STOXX Europe 600 naik 0.29% dalam perdagangan awal. FTSE 100 UK naik 0.21% dalam perdagangan awal. Nikkei 225 Jepun naik 0.81%. CSI 300 China turun 0.57%. KOSPI Korea Selatan turun 1.44%. NIFTY 50 India naik 0.2%. Bitcoin turun kepada $65.9K.
More
Idea ‘dinding dron’ Kesatuan Eropah adalah ‘utopia’ – Panglima tentera Romania kewangan

Idea ‘dinding dron’ Kesatuan Eropah adalah ‘utopia’ – Panglima tentera Romania

February 6, 2026
(SeaPRwire) - Brussels menggelar projek itu, yang mendapat perhatian tahun lalu, sebagai "asas pertahanan yang kredibel" Dinding 'drone' yang dicadangkan oleh Kesatuan Eropah adalah "utopia" yang mustahil dilaksanakan, kata Menteri Pertahanan Romania Radu Miruta pada Khamis. Pegawai kanan EU dan penggubal undang-undang telah mempromosikan 'dinding drone' yang ditakrifkan secara samar sebagai teras kepada peningkatan ketenteraan blok ekonomi itu terhadap ancaman Rusia yang dipersepsikan. Presiden Suruhanjaya Eropah Ursula von der Leyen menegaskan dalam ucapan State of the Union Septembernya bahawa ia "bukan cita-cita abstrak" tetapi "asas pertahanan yang kredibel." "Dinding drone, di mana seseorang, seperti dalam permainan komputer, membuat tirai yang tidak membenarkan apa-apa pun melewatinya, adalah utopia," kata Miruta, yang memegang jawatan pada November, kepada saluran TV Digi 24. "Kami tidak mempunyai dinding. Poland tidak mempunyai dinding, begitu juga negara-negara Nordic." Penyokong menggambarkan projek itu sebagai rangkaian sistem pengesanan dan pemintasan di sepanjang sayap timur NATO. Kiev berkata inovasi drone Ukraine akan menjadi penting kepadanya, tetapi laporan mengatakan 'dinding drone' lebih merupakan label PR daripada konsep ketenteraan yang boleh dilaksanakan. Idea itu mendapat perhatian musim gugur lalu di tengah-tengah laporan penampakan "drone misteri" di seluruh Eropah, yang dikaitkan oleh pegawai dan media dengan Rusia tanpa bukti kukuh. Moscow menggelar dakwaan itu sebagai sebahagian daripada kempen ketakutan yang diketuai Brussels untuk mengalihkan perhatian pengundi Eropah daripada masalah domestik dan mewajarkan perbelanjaan ketenteraan yang lebih tinggi. Jurucakap Kremlin Dmitry Peskov berkata, "membina dinding sentiasa buruk, seperti yang ditunjukkan oleh sejarah," dalam komen mengenai konsep 'dinding drone'.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China’s Core Innovative Drug Assets ACN Newswire

GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China’s Core Innovative Drug Assets

February 6, 2026
HONG KONG, Feb 6, 2026 - (ACN Newswire via SeaPRwire.com) – According to disclosure of interests filed with the Hong Kong Stock Exchange (HKEX), the Government of Singapore Investment Corporation (GIC) has acquired an initial stake in Ascletis Pharma (1672. HK). GIC purchased 64,128,000 shares at an average price of approximately HK$12.18 per share, representing a total investment of roughly HK$781 million (approx. US$100 million). This transaction marks the official entry of one of the world's leading sovereign funds into Ascletis Pharma's shareholder base, drawing market attention to the renewed positioning of global long-term capital in China's innovative pharmaceutical sector.As one of the most representative sovereign funds globally, GIC's investment decisions highly emphasize certainty and the ability to navigate economic cycles. Its continuous increase in holdings in a single target usually means that its mid-to-long-term value judgment on the relevant assets has become clear. Unlike tactical transactions by short-term funds, GIC focuses more on whether the industrial logic is sound, whether R&D realization has time visibility, and the potential returns over the next few years.From a portfolio allocation perspective, GIC's decision to invest in Ascletis Pharma also reflects, to a certain extent, its recognition of the company's BD capabilities and pipeline structure. Ascletis Pharma's strategic layout in the innovative drug field exhibits differentiated characteristics, with a clear R&D pace. Its pipeline structure highly matches the "long-term, verifiable innovation" standards preferred by sovereign funds.As of now, GIC holds 64,128,000 shares of Ascletis Pharma, accounting for approximately 6.42% of the company's issued share capital (calculated based on 1,068,214,530 issued shares).Overall, GIC's current investment is more a strategic continuation of its presence in the Hong Kong innovative drug sector, rather than a short-term speculative behavior. As long-term capital gradually returns to fundamental pricing, core targets with genuine BD capabilities are re-entering the allocation scope of international capital. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Dua terbunuh dalam serangan AS ke atas bot narkotika disyaki di Pasifik – ketenteraan kewangan

Dua terbunuh dalam serangan AS ke atas bot narkotika disyaki di Pasifik – ketenteraan

February 6, 2026
(SeaPRwire) - Lebih 120 orang telah terbunuh dalam "perang terhadap dadah" Washington sejak September, menurut anggaran media Angkatan Amerika telah melancarkan serangan lain ke atas kapal yang disyaki mengedar dadah di Pasifik Timur, menyebabkan dua orang terbunuh, menurut US Southern Command. Dalam kenyataan yang dikeluarkan pada Jumaat, badan tersebut menyatakan operasi itu dijalankan sehari sebelumnya di bawah arahan panglimanya, Gen. Francis L. Donovan, dan mensasarkan sebuah kapal "dikendalikan oleh Organisasi Pengganas Ditetapkan." Ia tidak memberikan butiran mengenai kumpulan mana kapal itu milik. Pasukan itu mendakwa, dengan merujuk data perisikan, bahawa kapal itu bergerak sepanjang "laluan pengedaran dadah yang diketahui" dan "terlibat dalam operasi pengedaran dadah." Tiada angkatan tentera Amerika yang cedera dalam serangan itu, kenyataan itu menambah. Pasukan itu juga mengeluarkan sebuah video yang menunjukkan sebuah kapal bersaiz kecil kena dua letupan di lokasi yang tidak dinyatakan. Serangan itu adalah sebahagian daripada apa yang pentadbiran Presiden Amerika Donald Trump gambarkan sebagai "perang terhadap dadah," dengan tumpuan memusnahkan kapal yang disyaki dan bukannya menaikinya. Kempen itu bermula pada September 2025 dan telah menyebabkan 128 orang terbunuh dalam lebih 36 serangan di Caribbean dan Pasifik timur, menurut pengiraan AP, walaupun kadarnya telah menurun sejak awal Januari 2026. Pada 3 Januari, Amerika Syarikat telah menculik Presiden Venezuela Nicolas Maduro, yang didakwa mempunyai hubungan dengan perdagangan dadah. Maduro, yang sedang menunggu perbicaraan di New York, telah menafikan dakwaan itu, dengan mengatakan ia hanya menjadi alasan untuk perubahan rejim. Pengkritik "perang terhadap dadah" juga mempersoalkan asas undang-undang serangan itu, dengan mengatakan pentadbiran gagal mengemukakan bukti yang cukup untuk membuktikan kapal-kapal itu dikendalikan oleh kartel dadah. Mereka juga menekankan bahawa Kongres tidak membenarkan penggunaan kekuatan tentera. Trump telah mempertahankan serangan itu, dengan mendakwa ia telah mengurangkan aliran dadah melalui laut ke Amerika Syarikat sebanyak 94%. Beberapa pemimpin serantau telah menyuarakan kebimbangan tentang kempen itu, termasuk Presiden Colombia Gustavo Petro, yang telah mengutuk serangan itu sebagai tidak sah dan mengingatkan tentang ketegangan yang meningkat, walaupun ini tidak menghalang pertemuannya dengan Trump awal minggu ini.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share ACN Newswire

GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share

February 6, 2026
HONG KONG, Feb 6, 2026 - (ACN Newswire via SeaPRwire.com) – According to the disclosure of interests information released by the Hong Kong Stock Exchange, on 5 February, GIC Private Limited made its first equity investment in Ascletis Pharma (01672) by acquiring 64,128,000shares at a price of HKD12.18per share, involving a total consideration of approximately HKD781.08million (equivalent to approximately USD100.01 million). Following the transaction, GIC's shareholding in Ascletis Pharma amounted to 64,128,000shares, representing a shareholding percentage of 6.42%, marking GIC's initial entry into the company's shareholder base. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Simbol status terbaru Gen Z ialah berlari maraton — dan ini berita buruk untuk Gucci, Louis Vuitton, dan Hermès berita

Simbol status terbaru Gen Z ialah berlari maraton — dan ini berita buruk untuk Gucci, Louis Vuitton, dan Hermès

February 6, 2026
(SeaPRwire) - Gen Z telah menolak impian memiliki beg Birkin dan sebaliknya memilih kasut sukan. Ketika barangan mewah bergelut untuk memikat generasi muda pengguna yang belum mengumpul cukup wang untuk membeli beg tangan berharga lima angka, golongan berusia 20-an sebaliknya terpesona dengan aktiviti kecergasan yang lebih mampu milik. “Jika anda mampu bangun sebelum kerja atau selepas kerja dan berlatih serta mempunyai kasut larian dan anda boleh melakukannya, saya sangat memuji anda,” kata influencer New York City, Chloe Hechter dalam satu temu bual. “Saya rasa mengatakan bahawa anda telah berlari—atau anda berlari, atau anda akan berlari—Maraton Bandar Raya New York adalah satu pengaruh yang besar di New York.” Gen Z, generasi yang menamatkan pengajian kolej dan mula mendaki tangga kerjaya, telah dilanda ribut sempurna era COVID-19 yang terdiri daripada masalah kewangan dan dorongan ke arah komunikasi maya yang telah mendorong mereka untuk mengutamakan segala-galanya berkaitan kecergasan, kata Jessica Ramírez, pengasas bersama dan pengarah urusan firma trend peruncitan the Consumer Collective. Penurunan ekonomi selepas lonjakan pengambilan pekerja pasca-pandemik membahayakan aspirasi kerjaya Gen Z untuk mencari atau dinaikkan pangkat dalam pekerjaan, menjadikannya lebih sukar untuk mencapai kejayaan. Keinginan untuk hobi yang murah, digabungkan dengan keinginan untuk melarikan diri daripada rasa terasing yang diburukkan lagi semasa pandemik, telah mewujudkan trend yang semakin berkembang untuk mencari komuniti di gimnasium atau kelab larian, di mana mengeluarkan banyak wang adalah pilihan. “Dengan larian, ia adalah sukan termudah, di mana anda boleh keluar sahaja, memakai sepasang fon kepala,” kata Ramírez kepada The New York Times. “Gen Z paling terkesan oleh kesan kesepian, dan banyak komuniti sukan ini—larian menjadi yang terbesar—ia menawarkan komuniti.” Berlari mengelilingi barangan mewah Hechter tidak membayangkan penguasaan Gen Z dalam perlumbaan di bandar kelahirannya. Maraton Bandar Raya New York 2025 mempunyai 50,000 pemohon, hampir 11,000 daripadanya adalah berusia 25 hingga 29 tahun, membentuk kumpulan pelari terbesar dengan hampir 25%. Sebagai perbandingan, hanya 17% penamat maraton berusia di bawah 30 tahun pada tahun 2022. Jenama kecergasan telah meraih keuntungan daripada kegilaan kecergasan generasi ini, dengan jenama kasut sukan On merancang untuk membuka kedai fizikal pertama mereka di New York City pada April 2025. Alo Yoga telah melancarkan kedai dan "sana yoga" di Roblox, platform metaverse dan permainan dalam talian yang digemari oleh Gen Alpha. Bagi Gen Z, memakai kasut sukan dan memanaskan badan mungkin lebih popular daripada membeli-belah di kedai mewah. Selain itu, analisis Hechter mengenai barangan dan acara yang paling dicari oleh Gen Z juga termasuk tikar yoga Alo atau Lululemon dan menjadi ahli gim premium seperti Equinox dan Solidcore sebagai berprestij sama seperti berlari maraton itu sendiri. “Jika anda datang ke CorePower dengan, seperti, tikar Alo atau tikar yoga Lululemon, saya tahu anda serius,” katanya. “Anda boleh sahaja mendapatkan tikar yoga berharga $15 dari TJ Maxx, tetapi anda tidak melakukannya.” Sementara itu, industri barangan mewah mengalami perlambatan yang lebih luas: Laporan Jun 2025 daripada Bain & Co. mendapati penurunan dalam jualan barangan mewah peribadi pada awal 2025, serta kehilangan kira-kira 50 juta pelanggan. Barangan mewah peribadi mengalami pukulan terbesar, jatuh daripada perbelanjaan $435 bilion pada 2023 kepada $429 bilion pada 2024, penguncupan pertama dalam kategori itu dalam tempoh 15 tahun, selain daripada pandemik. Malah Ketua Pegawai Eksekutif LVMH Bernard Arnault mengakui minggu lalu bahawa industri secara keseluruhannya telah mengalami akibat ketegangan geopolitik dan ketidakpastian ekonomi. Gen Z, khususnya, juga nampaknya tidak mempunyai selera untuk membeli barangan bernilai tinggi. Tinjauan daripada akhir 2025 mendapati 72% pembeli barangan mewah Gen Z lebih suka memiliki beg tiruan "Wirkin" daripada beg Hermes Birkin yang asli. Outlet itu mengaitkan keutamaan untuk barangan tiruan dengan fakta bahawa generasi itu mungkin tidak mampu membeli barangan ini, dan akibatnya, tidak menghargainya seperti golongan yang mempunyai kekayaan yang mantap. “Wang adalah kebimbangan,” kata Ramírez. Kebangkitan analog Tetapi usaha untuk berlari dan kecergasan bukan sekadar kewangan, menurut Ramírez. Ia bertepatan dengan Gen Z mencari bukan pulau-pulau mewah, tetapi kebangkitan semula barangan fizikal seperti rekod vinil, buku paperback, dan media fizikal lain. Golongan muda adalah penduduk asli digital, tetapi sesetengahnya mungkin merasakan bahawa kefasihan mereka dengan teknologi dan media sosial mungkin datang dengan mengorbankan pengalaman dunia sebenar. “Generasi muda mempunyai kerinduan yang hampir melankolis kerana begitu sedikit kehidupan mereka terasa nyata,” kata Pamela Paul, pengarang 100 Things We’ve Lost To The Internet. “Mereka mula menyedari bagaimana internet telah mengubah kehidupan mereka, dan mereka cuba menghidupkan semula persekitaran bersemuka, berteknologi rendah ini yang generasi lebih tua anggap remeh.” Memperoleh kedewasaan dalam pandemik, generasi ini juga sedar kesihatan, lebih kerap bersenam berbanding rakan sejawat milenium mereka, dan lebih cenderung untuk membeli produk kesihatan dan kecergasan daripada syarikat seperti Nike dan Lululemon. Tinjauan daripada 2024 mendapati 73% Zoomers aktif adalah ahli kelab kesihatan atau gim. Itu berbanding 72% milenium dan 54% Gen X. “Saya tidak fikir [peralihan ke arah] sukan adalah satu trend,” kata Ramírez. “Ia adalah perubahan gaya hidup, yang jauh lebih signifikan.” Bagaimana barangan mewah cuba memenangi Gen Z Ramírez melihat trend ini tercermin dalam jenama yang diminati oleh Gen Z, kerana generasi itu tidak sepenuhnya mengelak barangan mewah. Walaupun jenama seperti Louis Vuitton dan Gucci bergelut untuk menarik minat pembeli muda, jenama seperti Prada telah memanfaatkan minat terhadap barangan mewah yang lebih kecil dan keinginan untuk kemewahan bersaiz gigitan yang lebih berasaskan pengalaman, menurut Ramírez. Prada telah membuka kafe di Seoul yang menyajikan latte yang ditaburi koko dalam bentuk logo Miu Miu. “Di situlah anda melihat semua rumah mewah ini benar-benar mencipta strategi gaya hidup ini… memberi mereka hadiah kecil itu… memberi mereka sesuatu yang boleh mereka teruja dan kenal pasti,” kata Ramírez. “Saya rasa itu amat penting dalam latar belakang makro yang goyah hari ini secara umum.” Beliau menambah bahawa jenama yang berjaya melihat barangan yang lebih kecil ini sebagai cara untuk mendapatkan kepercayaan Gen Z, supaya apabila golongan muda ini akhirnya memperoleh gaji yang lebih besar, mereka akan membelanjakan wang mereka pada jenama yang sama. “Jenama yang memanfaatkan minat dan pemahaman pengguna, ia benar-benar akan mewujudkan kesetiaan itu apabila pengguna ini mempunyai wang: ‘Hei, jenama itu benar-benar memahami saya. Mereka mempunyai barangan hebat ini, saya akan berbelanja lebih banyak dengan mereka,’” simpul Ramírez. “Jadi ia seperti meninggalkan serpihan roti.”Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More

COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization

February 6, 2026
HONG KONG, Feb 6, 2026 - (ACN Newswire via SeaPRwire.com) – Currently, digital transformation has become the core proposition of global industrial upgrading, and the manufacturing industry is also undergoing a disruptive transformation from being “experience-driven” to “data intelligence-driven”. In this process, the deep integration of artificial intelligence and industrial scenarios has become the key to resolving manufacturing complexity and unleashing productivity. The introduction of the Action Plan for Integrating and Empowering Industrial Internet and Artificial Intelligence by MIIT further marks the upgrade of “AI + Manufacturing” from an optional pathway to a mandatory one, giving rise to a blue ocean of value worth tens of trillions.As a deep participant and leader in the digital and intelligent transformation of the manufacturing industry, COSMOPlat IoT Technology Co., Ltd. (“COSMOPlat”) has, based on its profound understanding of massive data and complex scenarios in the industrial field, built a full-stack AI technology system that includes training and inference platform, large models, intelligent agent development and application platforms. This has not only redefined the implementation path of industrial digitalization and intelligentization, but also continuously strengthened its technical barriers in industrial practice, building a solid and difficult-to-replicate moat, and is expected to benefit deeply from the dividends of industrial digital and intelligent transformation and development. On January 30, COSMOPlat submitted a listing application to the HKEX, embarking on a new chapter of value realization.AI Restructuring Industrial Digitalization: Full-stack Architecture and Flywheel Effect Build Core BarriersIn traditional perception, the industrial internet is a platform for data connection and circulation, and its technical boundaries remain more at the levels of equipment access, data collection, and process visualization. However, through its original “space-air-ground integrated” full-stack AI technology system, COSMOPlat has deeply embedded “AI+” into its technology architecture, achieving an intelligent closed-loop across the entire chain from perception and decision-making to execution, transforming data into intelligent decision-making capabilities, completely overturning the technology logic of the traditional industrial internet, and building an inimitable technology moat.At the “space” level, COSMOPlat utilizes “COSMOMind”, the first domestic vertical large model based on an industrial internet platform, as its decision-making hub. “COSMOMind” deeply integrates Haier Group's over 40 years of manufacturing knowledge, as well as expert models and high-quality multimodal datasets accumulated on the COSMOMind Industrial Big Data. It possesses significant advantages in industrial scenario analysis, knowledge Q&A, and logical reasoning, with a retrieval accuracy rate of up to 93% in industrial knowledge fusion and retrieval. Through the "one industry, one model" strategy, COSMOPlat has developed industry-specific large models for enterprises in home appliances, energy and chemicals, energy and carbon industries, providing intelligent decision-making support for major industrial scenarios including research and development design, production manufacturing, operation services and dual-carbon management.Industry intelligent agents and industrial software serve as the “air link”, transforming the decision-making instructions of large models into more flexible human-machine interaction methods and more efficient execution capabilities. As of the Latest Practicable Date, COSMOPlat has developed 57 industrial intelligent agents covering over 40 core scenarios across 3 major industries, which can handle key industrial functions such as process optimization, equipment management, and smart energy and carbon, helping customers achieve intelligent control of industrial processes, shorten process parameter adjustment cycles, improve equipment operation and maintenance efficiency, and reduce production energy consumption and energy costs.At the “ground” level, intelligent terminals and automation equipment, acting as the executing limbs, transform AI capabilities into actual production actions and integrate them into the entire manufacturing process, achieving efficient synergy among data, equipment and scenarios, driving industrial AI from isolated intelligent applications to domain-wide intelligence, creating value-added throughout the entire process for customers across various industries, and maximizing the release of data value.Relying on the “space-air-ground integrated” full-stack AI technology system, COSMOPlat has achieved full-link intelligence across “perception-analysis-decision-execution-feedback”, forming a unique flywheel effect of “data accumulation—model refinement—intelligent agent deployment—data reinforcement”, achieving self-reinforcement and a virtuous cycle where “more data is generated through use, models become more precise through use, and intelligent agent scenarios become broader through use”, enabling COSMOPlat's AI capabilities to continuously evolve in practice and building a solid technology barrier.Practical Evidence: AI Empowerment from Concept to Significant Scenario Implementation ResultsThe value of technology must ultimately be tested by the market. COSMOPlat has demonstrated through numerous benchmark cases that its AI empowerment has moved beyond the “proof of concept” stage and is capable of delivering tangible economic benefits to enterprises.In the petrochemical industry, COSMOPlat has developed the world's first petrochemical large model covering the entire industry chain, entire ecosystem chain, and entire value chain, which has been implemented in a large-scale petrochemical enterprise. Based on the model, the Company has developed 38 intelligent agents, such as the dynamometer intelligent assistant and the aldehyde separation tower process optimization agent, covering scenarios such as oilfield extraction, oil and gas refining and chemical processing, and production safety, with an average efficiency increase of 20%. Taking the dynamometer intelligent assistant as an example, based on the professional capabilities of whole-network search and the COSMOMind, this intelligent agent can “read and understand” dynamometer data of industrial equipment such as deep well pumps, accurately identify equipment failures and provide disposal suggestions, improving the efficiency of oil well equipment failure diagnosis and disposal by more than 50%; the aldehyde separation tower process optimization assistant integrates historical data and expert knowledge, enabling dynamic identification and adjustment suggestions for key parameters, providing decision-making assistance for operators, and significantly enhancing quality control precision and the product first-time conversion rate; the intelligent oil blending assistant quickly generates optimal blending schemes through interpolation algorithms and non-linear programming models, balancing product performance with green production requirements, fully validating the practical value of AI in the heavy chemical industry.In core manufacturing scenarios, COSMOPlat integrates AI technology throughout the entire chain of R&D, production, operation and maintenance. On the R&D side, taking a home appliance interconnected factory selected as a world “lighthouse factory” as a typical example, an AIGC virtual design assistant was introduced. Based on massive user preference data and an expert design asset library, it generated core solutions for three-drum washing machines. By simulating inner drum operation scenarios in advance to construct a dynamic balance optimization model, it solved the industry pain point of “collisions and interference” during multi-drum operation at the source; on the production side, the injection molding industrial intelligent agent, through deep learning of injection molding professional knowledge, equipment operation data, and process data, etc., precipitated the debugging methods that previously existed only in the minds of process technicians into various intelligent algorithms, ultimately forming professional injection molding knowledge Q&A and automated process parameter recommendation capabilities, building the most powerful “industrial brain” in the field of injection molding.In the energy sector, COSMOPlat’s energy-carbon model (COSMOMind for energy-carbon) is the first energy-carbon model originating from sustainable lighthouse factory practices. Based on this model, COSMOPlat offers enterprises and industrial park users an Energy-Carbon Management Platform and end-to-end smart-energy solutions, helping customers lower energy cost, improve utilization and advance green manufacturing. These cross-industry and multi-scenario success stories strongly demonstrate the practical effectiveness and replicability of COSMOPlat’s AI solutions.From an industrial cycle perspective, as the manufacturing system grows increasingly complex and cost and efficiency constraints intensify, enterprises' demand for end-to-end digital and intelligent transformation will continue to rise, ensuring long-term certainty in industry development.COSMOPlat has pioneered the “space-air-ground integrated” technology system centered on large industrial models, with intelligent agents deeply embedded in production processes. This delivers a closed loop of perception, decision-making, and execution. Through multi-industry and multi-scenario validation, it demonstrates that AI possesses the capability to continuously generate industrial value. As application scenarios continue to expand, intelligent agents scale up, and the data flywheel effect intensifies, COSMOPlat is poised to translate its technological leadership into heightened platform stickiness and greater value per customer. Riding the wave of digital transformation, it is unlocking greater potential for value growth. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

Distinct Healthcare Successfully Listed on HKEX, Bolstered by Premium Customer Base and All-Star Cornerstone Investors

February 5, 2026
HONG KONG, Feb 6, 2026 - (ACN Newswire via SeaPRwire.com) – On February 6, Distinct Healthcare Holdings Limited ("Distinct Healthcare" or the "Company", Stock Code: 2677.HK), a leading player in China's mid-to-high-end consumer healthcare services market, was successfully listed on the main board of the Hong Kong Stock Exchange, emerging as a high-quality and rare private healthcare gem in the Hong Kong stock market. This marks the beginning of a new chapter in the Company's scaled and high-quality development.On its debut, Distinct Healthcare delivered a standout debut, opening sharply higher at HK$81 per share (a 35.23% premium to the offer price), well above the offer price—an indication of strong capital market recognition of the Company's growth potential. The active trading and high investor enthusiasm further corroborate the market's firm confidence in the consumer healthcare services sector and the Company's core value.Possessing a Large Customer Base with Continuously Improving ProfitabilityAs the third-largest provider of private mid- to high-end healthcare service in China, Distinct Healthcare has always adhered to its patient-oriented core principle, placing patient well-being at the forefront. This approach has enabled the Company to gradually build a large and high-quality patient base, leading the industry in both user scale and return rate.From 2022 up to the eight months ending 31 August 2025, the total number of patients served by its healthcare institutions in China rose from 162,393 to 212,180, and the total number of paid patient visits of its healthcare service institutions and tele-healthcare service platform grew from 529,829 to 642,132.Patient loyalty has continued to rise, with the patient return rate steadily climbing. In 2022, 2023, 2024 and the eight months ended 31 August 2025, the patient return rates reached 75.7%, 78.2%, 80.0% and 82.7%, respectively. This robust growth is a strong testament to the market and patients' high recognition of Distinct Healthcare's service quality.Leveraging its large and high-quality customer base and the advantages of its standardized medical services, Distinct Healthcare has achieved steady business growth "without relying on medical insurance subsidies or excessive marketing expenditure". Financial data shows the Company's total revenue increased steadily from RMB473 million in 2022 to RMB959 million in 2024, doubling its revenue in two years and achieving a compound annual growth rate (CAGR) of 42.3%, demonstrating strong growth momentum.In terms of profitability, the Company achieved a critical milestone by turning profitable in 2024, with an adjusted net profit of RMB10.7 million. This represents a qualitative leap from scale-driven growth to profitability-driven growth.Strong Line-up of Cornerstone Investors and Clear Strategic Plan Support High-Quality DevelopmentDistinct Healthcare has attracted a strong roster of cornerstone investors in this IPO, including Health Vision, Kingmed Diagnostics, Mininglamp Technology, and Galaxy Dynasty. Together, they subscribed for a total of approximately HK$90.7876 million. The active participation of these renowned, high-quality institutional investors fully reflects their high recognition of Distinct Healthcare's core competitiveness, business model, and future development prospects, and will also provide powerful resource support and brand endorsement for the Company's subsequent development, helping it to further expand its industry influence.Regarding the use of IPO proceeds, Distinct Healthcare has formulated a clear strategic plan to ensure the proceeds are effectively deployed to support the Company's high-quality growth. Approximately 35% of the net proceeds will be allocated to digitalization and intelligent upgrades. By building a professional talent pool for medical AI applications, establishing strategic partnerships with leading research institutions and technology companies and making external procurements, while leveraging internal IT and data technology departments to iteratively optimize existing IT systems, the Company will deploy advanced AI technologies, optimize medical service workflows and enhance diagnostic efficiency as well as operational effectiveness.Approximately 30% of the net proceeds will be used for service network expansion and upgrades, primarily focusing on enhancing the diagnostic environment and equipment at existing medical service institutions. It will also advance the layout of new institutions, including relocating an existing institution in Shenzhen and establishing new institutions in key cities such as Hangzhou and Shanghai, thereby further expanding and improving service coverage in key domestic regions.Approximately 25% is earmarked for strategic mergers and acquisitions, acquire high-performing medical service institutions with strong synergies in first-tier and new first-tier cities when suitable opportunities arise, aiming to rapidly expand market share and strengthen regional competitiveness. The remaining approximately 10% will be used as working capital and for general corporate purposes, providing stable financial support for daily operations and business expansion.This clear strategic roadmap not only charts a clear course for the Company's future growth, effectively enhancing its core competitiveness and sustainability, but will also further reinforce its leading position in China's private mid-to-high-end healthcare sector. It will help propel the Company to new heights, achieving its long-term goals of scaled and high-quality development.This successful listing on HKEX represents a significant milestone in Distinct Healthcare's development journey, marking its official entry into a new phase driven by both "capital and industry". It will further elevate the Company's brand influence and financing capabilities, injecting powerful momentum for its future growth.Moving forward, Distinct Healthcare will remain true to its founding aspirations, staying focused on the mid-to-high-end healthcare services segment. It will continue to enhance medical service quality and patient experience, further unlock its growth potential and deliver sustainable long-term returns to its shareholders. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

Muyuan Foods Makes Hong Kong Debut Today: Strong Cornerstone Investor Backing Fuels Rapid Earnings Growth, Embarking on New Journey of Internationalization

February 5, 2026
HONG KONG, Feb 6, 2026 - (ACN Newswire via SeaPRwire.com) – On 6 February, Muyuan Foods Co., Ltd. ("Muyuan Foods" or the "Company", Stock Code: 2714.HK), a global leader in the pork industry, officially listed on the Main Board of The Stock Exchange of Hong Kong Limited today, marking the beginning of a new chapter in the Company's international development.Powerful Cornerstone Investors Underscore Muyuan’s Industry LeadershipFor this Hong Kong IPO, Muyuan Foods successfully attracted a prestigious lineup of cornerstone investors, including Charoen Pokphand Foods, Wilmar International Limited (Wii Pte. Ltd. and HPRY), Sinochem Hong Kong, Hong Kong Henan AgriInternational, FIL Investment, RBC Global Asset Management (Asia) Limited and Ping An Life Insurance Company of China, Ltd., and other renowned institutions—14 in total—with combined subscription amounting to US$685 million. This formidable cornerstone investor group not only provides the Company with stable financial support but also brings abundant industrial resources and an international perspective, laying a solid foundation for its subsequent global expansion and valuation enhancement.As a technology-driven pork industry leader, Muyuan Foods has deep expertise cultivated over many years in the industry and has established a uniquely advantageous vertically integrated business model. Its operations comprehensively cover the entire pork industry chain, including hog breeding, hog farming, feed production, as well as slaughtering and meat production. Leveraging synergistic advantages across the entire chain, the Company has steadily maintained its leadership position in the hog farming industry.According to statistics from Frost & Sullivan, since 2021, measured by hog production capacity and hog sales volume, Muyuan Foods has become the world's largest hog farming enterprise. Its hog sales volume has ranked first globally for four consecutive years, solidifying its position as the industry leader. In terms of market share, the Company's global market share steadily increased from 2.6% in 2021 to 5.6% in 2024. As of 2024, this market share already exceeded the combined market share of the world's second to fourth largest participants in the hog farming industry, further widening the gap with peers and continuously highlighting its core competitiveness.Steady Earnings Growth Maintained; Active Overseas Market Expansion Strengthens CompetitivenessRelying on its full industry chain layout and efficient operational management, Muyuan Foods has maintained steady earnings growth in recent years, with profitability continuously improving, demonstrating the Company's operational resilience through solid business data. Data shows that the Company's revenue scale grew steadily from RMB124.826 billion in 2022 to RMB137.947 billion in 2024. Net profit surged significantly from RMB14.933 billion in 2022 to RMB18.925 billion in 2024, indicating remarkable growth and continuously optimized profitability. Entering 2025, the Company's growth momentum further accelerated. In the first nine months of 2025, the Company achieved operating revenue of RMB111.790 billion, a year-on-year increase of 15.5%, and realized a net profit of RMB15.112 billion, a substantial year-on-year increase of 34.4%. The double-digit growth in both revenue and net profit fully demonstrates the Company's strong development momentum and favorable profit outlook.While consolidating its leading position in the domestic market and achieving rapid self-development, Muyuan Foods has consistently anchored its global development strategy, actively expanding into overseas markets. Using the export of technology and equipment as a key approach, it empowers the upgrading of the global hog farming industry and builds an international farming ecosystem. In 2024, the Company entered into a deep strategic partnership with BAF Vietnam Agriculture, providing services including hog house design, biosecurity management, odor control solutions and smart hog farming to help its partner optimize farming efficiency, reduce operational costs, and practice environmentally responsible farming.The smooth progress of this cooperation marks a crucial first successful step for Muyuan Foods in its global layout, accumulating valuable experience for subsequent overseas market expansion. On the other hand, leveraging the vast potential of overseas markets, Muyuan Foods will further achieve optimized resource allocation and efficient synergy on a global scale, continuously broadening its corporate growth boundaries and diversifying profit sources, thereby solidifying its core advantages and enhancing comprehensive competitiveness.Overall, the successful listing in Hong Kong not only signifies that Muyuan Foods has formally entered a new stage of internationalized development, establishing an important bridge connecting global capital and resources, but also indicates that the Company's operational management level, industry competitiveness, and development potential have gained broad recognition from the international capital market. In the future, Muyuan Foods will seize this listing opportunity, adhere to the philosophy of technology-driven and green development, continue to deepen its involvement in the entire pork industry chain, constantly strengthen its core competitiveness, steadily advance its global layout, further consolidate its position as the global leader in the hog farming industry, and open up broader growth space. Its future development is worthy of market anticipation. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis ACN Newswire

Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis

February 5, 2026
HONG KONG, Feb 6, 2026 - (ACN Newswire via SeaPRwire.com) – Everest Medicines today announced that China's National Medical Products Administration (NMPA) has approved VELSIPITY(R) (etrasimod arginine tablets) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.UC is a chronic, relapsing, non-specific inflammatory bowel disease. In China, the incidence and prevalence of UC are accelerating, with a clear trend toward younger patients. The patient population is projected to increase from approximately 0.98 million in 2025 to 1.50 million by 2031.There remains a critical need for therapies that offer sustained and comprehensive disease control.As a next-generation selective S1P receptor modulator, VELSIPITY(R) offers the potential for rapid onset of action, and long-lasting clinical remission and mucosal healing through an oral, once-daily regimen for adult patients with moderately to severely active UC.The approval was based on results from the Asian multicenter Phase 3 ENLIGHT UC study (ES101002) and the global ELEVATE UC Phase 3 program (ELEVATE UC 52 and ELEVATE UC 12). The ENLIGHT UC study is the largest Phase 3 trial of moderately to severely active UC in Asia completed to date, with 340 eligible subjects randomized to treatment with VELSIPITY(R) or placebo. The study results showed that, VELSIPITY(R) demonstrated statistically significant and clinically meaningful improvements across all primary and secondary efficacy endpoints during both the 12-week induction period and the 40-week maintenance period. The safety profile of VELSIPITY(R) was consistent with previous studies, with no new safety signals observed. The study confirms the efficacy and safety of VELSIPITY(R) in this population, with results published in The Lancet Gastroenterology & Hepatology.From a clinical value perspective，VELSIPITY(R) is a once-daily oral therapy with rapid onset of action, strong mucosal healing efficacy, and a favorable safety profile. Prof. Chen Minhu, Academic Leader and Chief Expert of the Department of Gastroenterology at The First Affiliated Hospital of Sun Yat-sen University noted that UC is rapidly increasing in China and follows a relapsing course that significantly impairs quality of life and places a substantial burden on both patients and the healthcare system. Achieving mucosal healing is a widely recognized treatment goal in clinical guidelines, as it improves symptom control, reduces relapse risk, and supports long-term disease management.“UC treatment in China has long faced limited efficacy, high relapse rates, safety concerns, and inconvenient dosing. Despite available biologics and small-molecule therapies, unmet clinical needs persist,” said Prof. Wu Kaichun of the First Affiliated Hospital of AFMU, principal investigator of VELSIPITY(R)’s Asian clinical trial. “Its approval represents an important milestone and validation, providing patients with a novel treatment option and advancing UC management.”“Autoimmune diseases have long-term impacts on patients worldwide, with significant unmet clinical needs persisting both in China and globally,” said Mr. Yifang Wu, Chairman of the Board of Everest Medicines. “The approval of VELSIPITY(R) underscores the clinical value of innovative therapies for UC and reflects Everest Medicines’ sustained commitment to advancing drug development in line with international R&D standards. We look forward to expanding our global reach and providing patients with broader access to innovative treatment options.”“Its approval in China addresses a critical unmet medical need and introduces a novel oral therapy promoting deep mucosal healing,” said Mr. Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “We are committed to rapidly commercializing VELSIPITY(R) and working toward its inclusion in the National Reimbursement Drug List to further expand patient access and affordability, benefiting more patients across China.”The clinical value of VELSIPITY(R) has been recognized in leading international clinical guidelines. Following its inclusion in the American Gastroenterological Association (AGA) Clinical Practice Guideline in December 2024 as a first-line treatment for ulcerative colitis , VELSIPITY(R) was also included in the American College of Gastroenterology (ACG) Clinical Guideline Update in June 2025, with strong recommendations supporting its use for both induction and maintenance of remission in patients with moderately to severely active UC. In 2024, VELSIPITY(R) was included in the Catalogues of Guangdong Province on Drugs and Medical Devices from Hong Kong and Macao in Urgent Clinical Use in Nine Mainland Municipalities of the Guangdong-Hong Kong-Macao Greater Bay Area, making it available at designated hospitals across the region. The localized production project for VELSIPITY(R) was launched at the Jiashan manufacturing site in March 2025, supporting its future commercialization in China.The successful approval of VELSIPITY(R) further strengthens Everest Medicines’ product portfolio in the field of autoimmune diseases and also forms a critical part of the 2030 strategy of the Company. This strategy is built on a dual-engine model of business development partnerships and in-house R&D, aiming to generate predictable value through commercialization while building long-term growth momentum through sustained innovation, thereby supporting pipeline continuity and sustainable development.The Company has established a portfolio of three commercial products and continues to develop a fully integrated commercial platform covering the entire product lifecycle.The Company targets annual revenue exceeding RMB10 billion by 2028, and RMB15 billion by 2030 (including approximately RMB9 billion from the existing pipeline and approximately RMB6 billion from newly in-licensed assets). Revenue is expected to grow at a compound annual growth rate (CAGR) of over 50% from 2025 to 2030 and to remain above 15% thereafte.Over the same period, the number of commercial products is expected to exceed 20, including NEFECON(R), VELSIPITY(R), XERAVA(R), Lerodalcibep and MT1013.Industry observers widely expect VELSIPITY(R) to become Everest's next blockbuster product, with analysts projecting peak sales of up to RMB 5 billion. As VELSIPITY(R) realizes its commercial potential, Everest's revenue mix and growth trajectory are expected to strengthen further. Looking ahead, Everest Medicines will continue to focus on therapeutic areas with significant unmet clinical needs. Leveraging its established commercialization capabilities and in-house R&D, the company aims to accelerate the launch of innovative therapies with global competitiveness, drive sustainable growth, and create greater health value for patients and society. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025 ACN Newswire

Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025

February 5, 2026
The accolades underscore Malaysia’s leading mineral water brand’s international achievements in their consistent pursuit of quality, excellence and industry leadershipKUALA LUMPUR, Feb 6, 2026 - (ACN Newswire via SeaPRwire.com) - Spritzer Berhad (“Spritzer” or “the Company”), Malaysia’s leading natural mineral water brand started the year on a strong note with a repeat of the annual recognition by two prestigious platforms, the Putra Brand Awards 2025 and the Superior Taste Award 2025. These achievements, their 10th and 15th recognition for each award respectively, reinforce Spritzer’s continued efforts and commitment to excellence, innovation and uncompromising standards in delivering high-quality natural mineral water locally and internationally.Spritzer Wins the Gold at the Putra Brand Awards 2025Spritzer was awarded the Gold Award in the Beverage – Non-Alcoholic category at the Putra Brand Awards (PBA) 2025, marking its 10th impressive win in the category, further reaffirming its status as Malaysia’s most trusted natural mineral water brand. The Putra Brand Awards are uniquely consumer-driven, with winners selected solely by Malaysian consumers as the judge of brand excellence across 30 categories. As a genuine reflection of the brand’s enduring consumer affinity, market confidence and brand relevance, the accolade is particularly meaningful.Spritzer’s win as the only mineral water brand amidst other well-loved global beverage brands in Malaysia highlights Spritzer’s competitiveness and firm standing in the national beverage landscape. The award was proudly accepted by Dr. Chuah Chaw Teo, Research and Development (R&D) Director of Spritzer, on behalf of the Company.“Winning the Putra Brand Awards for the 10th year affirms our consistent efforts to keep improving over the years,” said Dr. Chuah. “Behind this recognition lies years of disciplined research and development (R&D), stringent quality control, and continuous improvement across our operations and customer touch points. Our priority has always been to safeguard the integrity of our natural mineral water while innovating responsibly to meet the evolving needs of consumers and businesses.”Photo 1 and 2: Spritzer celebrates its Gold Award in the Beverage - Non-alcoholic Category at The Putra Brand Awards 2025A Superior Triumph in Taste GloballySpritzer’s product excellence was further validated internationally at the Superior Taste Award 2025, a globally respected certification conferred by the International Taste Institute in Brussels, Belgium known for its rigorous, professional sensory evaluation of food and beverage products. In 2025, Spritzer Natural Mineral Water secured the prestigious 3-Star Superior Taste Award for the 10th year, a milestone that continues to build on Spritzer’s 15-year legacy of recognition by the International Taste Institute.This long-term acclaim reflects the brand’s unwavering dedicated to delivering natural mineral water of exceptional quality and taste. It reaffirms Spritzer’s strong product capabilities, from taste profile to mineral composition, and its commitment to upholding stringent international benchmarks, further cementing its dominance in Malaysia’s bottled water sector and boosting consumer assurance across local and global markets.Established in 2005, the International Taste Institute is known for its independent, blind tasting methodology, conducted by a panel of over 250 world-class chefs and sommeliers from more than 20 countries worldwide. Products are assessed against strict sensory criteria and only those achieving a score above 70% are certified with the Superior Taste Award, with distinctions awarded based on performance.Photo 2: Spritzer secured the prestigious 3-Star Superior Taste Award for the 10th year for Spritzer Natural Mineral WaterReinforcing Trust Across Markets and StakeholdersTogether, these two awards signify strong domestic consumer confidence and international endorsement of product quality. Backed by robust R&D processes, consistent quality management and a long-standing heritage rooted in nature, Spritzer continues to demonstrate reliability and leadership in the industry.Dr. Chuah concluded, “These speak to the trust that consumers place in us every day. Spritzer remains committed to protecting the purity of our source, strengthening our innovation pipeline, and continuing to deliver natural mineral water of the highest quality that Malaysians and global consumers can rely on.”Supported by its partners, customers, and dedicated team, the Company will continue to represent Malaysian quality on the global stage.For more high-resolution photos, please download them here.About SpritzerEstablished in 1989, Spritzer is a leading Malaysian bottled water brand, sourcing natural mineral water from a protected 430-acre rainforest in Taiping. Naturally filtered through underground rock layers for over 15 years, our water is enriched with essential minerals like Silica, known to support skin, bones, hair, and nails.Combining smart manufacturing with sustainable practices, Spritzer ensures every bottle meets the highest quality and safety standards. Our packaging is 100% recyclable and made from recycled materials, reflecting our commitment to environmental stewardship and a circular economy.Tested annually by SIRIM to be free from microplastics, Spritzer offers consumers trusted, natural hydration. Our diverse product range includes Natural Mineral Water, Original and Flavoured Sparkling Water, Distilled Water, and Fruit-Flavoured Beverages—crafted to suit every lifestyle and occasion.With a clear vision to become a fully circular brand by 2030, Spritzer leads the industry in innovation, quality, and sustainability.Spritzer — where nature, innovation, and sustainability come together in every bottle.For more information, visit www.spritzer.com.myFor media inquiries please contact:Imelia KyraAssociate Consultant, Narro CommunicationsE: imelia@narrocomms.comWinnie ChinHead of Public Relations, Spritzer BhdE: winniecgl@spritzer.com.my Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Mitsubishi Motors Launches the All-New Versa Van in the Philippine Market JCN Newswire

Mitsubishi Motors Launches the All-New Versa Van in the Philippine Market

February 5, 2026
All-new Versa VanTOKYO, Feb 6, 2026 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced that Mitsubishi Motors Philippines Corporation (MMPC), a subsidiary of Mitsubishi Motors in the Philippines, began sales of the all-new Versa Van on February 6. The model is an OEM-supplied commercial vehicle by Nissan Motor Co., Ltd. (hereafter, Nissan).The all-new Versa Van offers five-row seating for up to 15 passengers and features a spacious interior optimized for transporting people, supporting a wide range of commercial applications, including shuttle services. Powered by a 2.5-liter inline four-cylinder diesel engine, the model delivers strong torque from the moment of acceleration, ensuring confident performance even when carrying many passengers or driving on steep inclines. With this new model, Mitsubishi Motors aims to strengthen its commercial vehicle lineup in the Philippines and meet customer needs alongside the existing L300 model.As Alliance partners, Mitsubishi Motors and Nissan are pursuing global collaboration in areas such as joint development and production of next-generation pickup trucks, as well as joining forces to drive business expansion in electrified vehicles. The OEM supply of the all-new Versa Van by Nissan for the Philippine market represents a tangible outcome of this collaboration. Mitsubishi Motors has also begun supplying Nissan with the Rogue Plug-in Hybrid for North America and the Navara for Oceania and has been supplying the Livina to the Philippine market since 2022 — an initiative that improves plant utilization and complements model lineups, building a mutually beneficial partnership. Furthermore, Mitsubishi Motors will receive OEM supply of an all-new EV model derived from Nissan’s new LEAF in 2026 and will introduce the model to the North American market in the latter half of the year.Mitsubishi Motors will continue to leverage diverse partnerships to expand its product lineup, strengthen regional operations, and accelerate initiatives that enhance profitability.About Mitsubishi MotorsMitsubishi Motors Corporation (TSE:7211) — a member of the Alliance with Renault and Nissan — is a global automobile company based in Tokyo, Japan, which has about 28,000 employees and a global footprint with production facilities in Japan and the ASEAN region. Mitsubishi Motors has a competitive edge in SUVs, pickup trucks and plug-in hybrid electric vehicles, and appeals to ambitious drivers willing to challenge convention and embrace innovation. Since the production of our first vehicle more than a century ago, Mitsubishi Motors has been a leader in electrification — launched the i-MiEV, the world’s first mass-produced electric vehicle in 2009, followed by the Outlander PHEV, the world’s first plug-in hybrid electric SUV in 2013. With a target of increasing the sales ratio of electrified vehicles to 100% by 2035, Mitsubishi Motors will deliver models that embody Mitsubishi Motors-ness and contribute to the realization of a carbon-neutral society.For more information on Mitsubishi Motors, please visit the company's website at https://www.mitsubishi-motors.com/en/ Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
Eternal Beauty Holdings Limited and Lane Crawford Debut Landmark Fragrance, Further Expanding Footprint in High-Margin Niche Fragrance Market ACN Newswire

Eternal Beauty Holdings Limited and Lane Crawford Debut Landmark Fragrance, Further Expanding Footprint in High-Margin Niche Fragrance Market

February 5, 2026
HONG KONG, Feb 6, 2026 - (ACN Newswire via SeaPRwire.com) – Eternal Beauty Holdings Limited (“Eternal Beauty” or the “Group”) (Stock Code: 6883.HK), a pioneer in China’s beauty and fragrance industry, announced its first-ever collaboration with Lane Crawford, a premier luxury department store, to launch an exclusive boutique niche fragrance section at its Harbour City store in Tsim Sha Tsui. The collaboration aims to further advances the Group’s strategy focused on high-margin niche fragrance brands, strengthens its premium brand footprint through an elite retail network, and captures the growing profit opportunities in the niche fragrance for Chinese Mainland and Hong Kong markets.The zone brings together four international niche fragrance brands under the immersive concept of a "Luxury Niche Perfume Street" with European flair, featuring Atkinsons, Clive Christian, Memo Paris and SOLFÉRINO, each presented with its unique style and heritage. Clive Christian and SOLFÉRINO are making their debut in Hong Kong, offering a rare experience to local high-end consumers. By leveraging Lane Crawford’s premium retail network that reaches high-spending customers, the Group effectively enhances brand penetration in the Hong Kong market. This initiative successfully introduces the Group’s portfolio into a core upscale retail destination in Hong Kong, demonstrating the Group’s strengths in channel expansion and retail curation, while further solidifying its brand influence and long-term growth momentum in the niche fragrance portfolio.Brand Introduction:AtkinsonsThe 200-year-old British "Royal Fragrance House" reinvents the rebellion and elegance of 19th-century English gentlemen, transforming historical formulas into a modern, contemporary aura.Clive ChristianThe first exclusive collectors’ boutique in Hong Kong: Clive Christian is a luxury British perfume house that creates the world's finest perfumes. A legacy of British craftsmanship, unparalleled quality in concentration and complexity, unashamedly indulgent and luxurious presentation.Memo ParisMemo Paris is a Parisian fragrance house, see each fragrance as a travel note captured in scent. Preserve memory of a journey to unique destination. Memo Paris sketches a delicate, emotional map of the world: a universe where memories become scents.SOLFÉRINODebuting brilliantly in Hong Kong, SOLFÉRINO is born in Paris, France, the brand draws inspiration from the historic architecture of this City of Lights, showcases French elegance with exceptional craftsmanship and presenting Parisian audacity and creativity.Ms. Wendy Lau, Executive Director of Eternal Beauty and Chairman of the International Fragrance Association, said, “With over 40 years of industry experience, Eternal Beauty has cultivated sharp market vision, distinctive taste, and profound expertise. This enables the Group to accurately identify and introduce brands that align with market trends and carry strong profit potential into the Greater China market, which continues to demonstrate vigorous consumption upgrade momentum. We are thrilled to partner with Lane Crawford, an influential luxury department platform in Asia, to create this exclusive boutique niche fragrance section in Hong Kong’s core luxury shopping district, leveraging the Group’s strengths in niche fragrance brand management and retail channel development. This is not only an important step for the Group to deepen the niche fragrance market, but also a concrete manifestation of our niche fragrance brand expansion strategy. Moving forward, the Group will continue to explore collaborations with top-tier retail partners. By introducing more niche brands with high growth potential, it will strengthen its long-term growth momentum and enhance sustainable profitability in the fragrance market.”Hong Kong's fragrance market continues to benefit from the momentum of the emotional economy, demonstrating relatively resilient growth against the backdrop of a steady recovery in the overall retail sector. In December 2025, the value of total retail sales in Hong Kong increased by 6.6% YoY; according to market’s outlook reports, the total retail sales in Hong Kong are expected to grow by nearly 8% in 2026, reaching approximately HKD 410 billion, indicating a continued recovery in local consumer demand. Ms. Chole Lam, Executive Director and Chief Executive Officer of Eternal Beauty, said, “In recent years, experiential retail and emotional consumption have gradually emerged as new retail trends, with emotional value playing an increasingly significant role in consumer decision-making. The ability to establish emotional resonance with consumers is becoming an important direction for brand expansion and product innovation. Emerging consumption segments, represented by high-end and niche fragrances, are more being regarded as categories that carry emotional value and lifestyle propositions, highlighting their growth potential in the retail recovery process.”Eternal Beauty has established an omni sales channel network over 400 cities across Chinese Mainland, Hong Kong and Macau. The cooperation with Lane Crawford is an important part of the Group’s retail channel strategy, aiming to enhance the consumer experience and sales conversion by leveraging the prime location and high customer traffic of the premium department store.Photo CaptionEternal Beauty and Lane Crawford debut landmark niche fragrance zone, bringing together four international niche fragrance brands under the concept of a "Luxury Niche Perfume Street". The zone immersively showcasing four distinctive and heritage-rich brands: Atkinsons, Clive Christian, Memo Paris, and SOLFÉRINO.Please download more high-resolution photos via link:https://drive.google.com/drive/folders/1nzCNkjNqd9f5RDCub3vmLpoesN52MJbS?usp=sharingAbout Eternal Beauty Holdings LimitedEternal Beauty Holdings Limited is the largest perfume group (apart from brand-owner perfume groups) in China (including Hong Kong and Macau) in terms of retail sales in 2023. It primarily sells and distributes products procured from third-party brand licensors, and deploys market for these brand licensors, offering such services as brand management, and designing and implementing customized market entry and expansion plans for their brands. The Group boasts large and diversified brand portfolios that include not only perfumes, but also color cosmetics, skincare products, personal care products, eyewear and home fragrances. As at 30 September 2025, it conducted product distribution and market deployment for a total of 74 external brands, including Hermès, Van Cleef & Arpels, Chopard, Albion and Laura Mercier, with products in different pricing tiers and of versatile features that meet the differentiated demands of consumers in Chinese Mainland, Hong Kong and/or Macau. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Establishment of the World’s First*1 Global Supply Chain to Introduce the Use of Renewable Plastics in Sony’s High-Performance Products JCN Newswire

Establishment of the World’s First*1 Global Supply Chain to Introduce the Use of Renewable Plastics in Sony’s High-Performance Products

February 5, 2026
TOKYO, Feb 6, 2026 - (JCN Newswire via SeaPRwire.com) - Sony Corporation (Sony), Mitsubishi Corporation, ADEKA CORPORATION , CHIMEI Corporation, ENEOS Corporation, Formosa Chemicals & Fibre Corporation, Hanwha Impact Corporation, Idemitsu Kosan Co., Ltd., Mitsui Chemicals, Inc., Neste Corporation, Qingdao Haier New Material Development Co., Ltd., SK Geo Centric Co., Ltd., Toray Industries, Inc., and Toray Advanced Materials Korea Inc. have jointly established the world’s first global supply chain consisting of fourteen companies across five countries and regions for the production of renewable plastics*2 that can be used in Sony’s high-performance audio-visual products. The various plastic materials manufactured through this supply chain are slated for use in Sony’s products that will be launched worldwide.＜Overview of the Entire Supply Chain＞(1) Production of renewable naphtha — Neste Corporation / (2) Production of renewable styrene monomer — Idemitsu Kosan Co., Ltd. / (3) Production of renewable polystyrene resin — Formosa Chemicals & Fibre Corporation / (4) Production of renewable para-xylene — SK Geo Centric Co., Ltd. / (5) Production of renewable para-xylene — ENEOS Corporation / (6) Production of renewable terephthalic acid — Hanwha Impact Corporation / (7) Production of renewable PET resin — Toray Advanced Materials Korea Inc. / (8) Production of renewable bisphenol-A — Mitsui Chemicals, Inc. / (9) Production of renewable polycarbonate (PC) resin — CHIMEI Corporation / (10) Production of renewable flame retardants — ADEKA CORPORATION / (11) Production of renewable PC/ABS resin — Qingdao Haier New Material Development Co., Ltd./ (12) Molding manufacturers / (13) Design and manufacturing of finished products — Sony CorporationHigh-performance products such as audio-visual equipment involve a wide variety of plastics, resulting in a complex supply chain that makes it difficult to visualize and manage the entire flow from raw materials. Additionally, plastic components that require high performance in terms of flame resistance and optical properties cannot be fully replaced with plastics produced through material recycling*3, hindering the further reduction of virgin fossil-based plastics in such products.To address these challenges, the fourteen companies collaborated to visualize the existing supply chain for Sony’s products, and created a new supply chain that enables the production of multiple types of renewable plastics from biomass resources with a mass balance approach*4. This allows Sony to proactively source raw materials for its products with the quality and properties equivalent to virgin fossil-based plastics. Defining the supply chain helps the companies track and document GHG (Greenhouse Gas) emissions data over the supply chain in a verifiable way, allowing participating companies to leverage the data to advance efforts to reduce their carbon footprint going forward.This initiative involving wide-ranging partners is part of the ‘Creating NEW from reNEWable materials' project, jointly launched by Sony, which aims to achieve zero usage of virgin fossil-based plastics through the introduction of renewable plastics, and Mitsubishi Corporation.Sony, Mitsubishi Corporation, and the supply chain partners will continue to actively promote the introduction of renewable plastics for high-performance products such as audio-visual products.About ProjectProject Introduction Video：https://youtu.be/3ba3t356sHI[About Sony Corporation]Sony Corporation is a wholly-owned subsidiary of Sony Group Corporation, responsible for the Entertainment, Technology & Services (ET&S) business. With the mission to "create the future of entertainment through the power of technology together with creators", we aim to continue to deliver Kando* to people around the world. Sony is actively promoting initiatives to reduce environmental impact as part of the Sony Group’s "Road to Zero" environmental plan, which aims for zero environmental impact by 2050. In this project, Sony will oversee the entire supply chain and promote the utilization of renewable plastics in our products. https://www.sony.co.jp/en/[About Mitsubishi Corporation]Mitsubishi Corporation (MC) is an integrated trading and investment company that develops and operates businesses across multiple industries together with its global network. MC has eight Business Groups that operate across virtually every industry: Environmental Energy, Materials Solution, Mineral Resources, Urban Development & Infrastructure, Mobility, Food Industry, Smart-Life Creation, and Power Solution. Through these eight Business Groups, MC’s activities have expanded far beyond its traditional trading operations to include project development, production, and manufacturing operations, working in collaboration with our trusted partners around the world. In this project, MC plays a comprehensive role in overseeing the supply chain, including credit delivery management, and promoting the introduction of renewable plastics into Sony products. https://www.mitsubishicorp.com/jp/en/[About ADEKA CORPORATION]ADEKA CORPORATION is a manufacturer of valuable materials with over 100 years of history. ADEKA aims to realize a sustainable society by globally expanding valuable materials that enrich people's lives, such as polymer additives that enhance plastic functionality, advanced semiconductor materials, environmental materials, food products, and agrochemicals. In this project, we manufacture flame retardants with biomass characteristics assigned using a mass balance approach. https://www.adeka.co.jp/en/[About CHIMEI Corporation]CHIMEI is a leading high-performance materials company that designs and manufactures advanced polymer materials, synthetic rubbers, and specialty chemicals, delivering innovative and sustainable solutions for industries worldwide. With a commitment to circularity, environmental responsibility, and close client collaboration, CHIMEI supports and partners with global companies to elevate product performance while jointly minimizing environmental impact. In this project, CHIMEI produces polycarbonate resin (PC) with assigned biomass characteristics using a mass balance approach. https://www.chimeicorp.com/en-US[About ENEOS Corporation]At ENEOS Corporation, our network has grown to about 12,000 ENEOS branded service stations across Japan. ENEOS is expanding business to accommodate energy transitions into sources like hydrogen and Synthetic Fuels in addition to petroleum and petrochemical products produced and manufactured at refineries and factories at various locations in Japan. The ENEOS Group aims to achieve both a stable supply of energy and materials and the realization of a carbon-neutral society, based on its commitment of “Supporting ‘today’s normal,’ taking the lead for ‘tomorrow’s normal.’” In this project, ENEOS manufactures paraxylene (PX) with assigned biomass characteristics using a mass balance approach. https://www.hd.eneos.co.jp/english/[About Formosa Chemicals & Fibre Corporation (FCFC)]FCFC is a comprehensive chemical company that manufactures petrochemical products, synthetic fibers, and plastics. FCFC implements a circular economy to achieve both environmental protection and industrial development, working on the development of green chemicals and the expansion of reusable materials. In this project, FCFC manufactures polystyrene (PS) with assigned biomass characteristics using a mass balance approach. https://www.fcfc.com.tw/[About Hanwha Impact Corporation]Hanwha Impact is a leading petrochemical and investment company, engaged in chemical products and next-generation energy solutions. Hanwha Impact aims to achieve a sustainable society through developing eco-friendly energy solutions and fostering future innovative technologies. In this project, Hanwha Impact produces high-purity terephthalic acid (PTA) with assigned biomass characteristics using a mass balance approach. https://www.hanwhaimpact.com/[About Idemitsu Kosan Co., Ltd.]The Idemitsu Group is engaged in the development, manufacture, and sales of a wide variety areas of Petroleum, Basic Chemicals, High-Performance Materials, Power/Renewable Energy, and in a variety of fields. Idemitsu Kosan is taking on the challenge of an energy transition to help realize a carbon-neutral and circular society by 2050. In the Basic Chemicals business, we are promoting the use of biomass feedstocks and advancing chemical recycling initiatives. In this project, Idemitsu Kosan produces styrene monomer (SM) using a mass balance approach. https://www.idemitsu.com/en/index.html[About Mitsui Chemicals, Inc.]Mitsui Chemicals is a chemical manufacturer that provides solutions for achieving a sustainable society, offering a wide range of products and services from basic chemicals to high-performance materials. Aiming for carbon neutrality by 2050, the company is working to reduce GHG emissions (Scope 1 and 2) and to maximize its contribution to GHG reductions throughout the entire product life cycle. In this project, Mitsui Chemicals produce biomass-derived bisphenol A (BPA) using the mass balance approach. https://jp.mitsuichemicals.com/en/index.htm[About Neste Corporation]Neste (NESTE, Nasdaq Helsinki) creates solutions for mitigating climate change and accelerating a shift to a circular economy. The company is the world’s leading producer of sustainable aviation fuel (SAF), renewable diesel, and renewable and circular solutions for the chemical and plastics industries. In this project, NESTE supplies renewable naphtha made from waste cooking oil and other renewable raw materials. https://www.neste.com/[About Qingdao Haier New Material Development Co., Ltd.]Haier is a global home appliance manufacturer originating, offering a wide range of products including refrigerators and washing machines. Haier New Materials, a subsidiary of the Haier Group, reduces carbon emissions and promotes the construction of a sustainable society by recycling regenerated plastic materials from disassembled home appliances. In this project, Haier produces recycled PC/ABS blended with a flame retardant with assigned biomass characteristics. https://www.haierdawn-plastics.com/[About SK Geo Centric Co., Ltd.]SKGC is a leading chemical company, offering petrochemical products such as olefins, aromatics and polymers. SKGC is upgrading our portfolio to provide more sustainable products in consumer’s daily lives. In this project, SKGC manufactures paraxylene (PX) with assigned biomass characteristics using a mass balance approach. https://www.skgeocentric.com/[About Toray Industries, Inc.]Toray Industries, Inc., is a global leader in advanced materials innovation, comprising more than 300 affiliated companies and approximately 48,000 employees worldwide. Since 1926, Toray Industries have continuously expanded our business portfolio—from Fibers & Textiles, to Resins & Chemicals, Films, Electronics & Information Materials, Carbon Fiber Composite Materials, Pharmaceuticals & Medical Products, as well as Water Treatment & Environment. April 2026 marks the 100th anniversary of Toray’s founding. In line with our Corporate Philosophy, “Contributing to society through the creation of new value with innovative ideas, technologies and products,” we will commit to delivering fundamental solutions to global-scale challenges. https://www.toray.com/ [About Toray Advanced Materials Korea Inc.]TAK is a comprehensive chemical manufacturer, offering various products from daily life to high-end industries. With consistent investing and innovation, TAK provides material solutions for climate crisis. In this project, TAK manufactures PET resin and film with assigned biomass characteristics using a mass balance approach. https://www.torayamk.com *1 In the manufacturing of audio-visual products, this initiative is regarded as a “world’s first” in that it visualizes the entire supply chain from raw materials to finished products and converts raw materials to biomass-based materials at mass-production scale.(Based on research conducted by Mitsubishi Corporation. At the time of announcement in Feb. 2026)*2 Plastics made from renewable biomass resources instead of fossil resources.*3 A method of reusing plastic materials by returning used plastics to their original form through physical processes such as crushing, cleaning, and melting, rather than discarding them.*4 This is a method of allocating the characteristics of specific raw materials, such as biomass resources, to a portion of the product based on the input amount of those materials when they are mixed with non-specific raw materials during the distribution and processing stages from raw materials to products.* "Sony", "SONY" logo and any other product names, service names or logo marks used in this press release are registered trademarks or trademarks of Sony Group Corporation or its affiliates. Other product names, service names, company names or logo marks are trademarked and copyrighted properties of their respective owners and/or licensors.* Visual content in this release may be removed without prior notice due to licensing or copyright reasons.* Kando is a Japanese word that roughly translates to the sense of awe and emotion you feel when experiencing something beautiful and amazing for the first time.MaterialityBased on the Three Corporate Principles, which serve as MC’s core philosophy, MC has continued to grow together with society by contributing to the sustainable development of society through its business activities while pursuing value creation. While continuously creating Shared Value guided by the Materiality, a set of crucial societal issues, MC will continue to strengthen its efforts towards sustainable corporate growth. Guided by this Materiality, MC will continue to strengthen its efforts towards sustainable corporate growth. Out of the six material issues relating to “Realizing a Carbon Neutral Society and Striving to Enrich Society Both Materially and Spiritually”, this project’s activities particularly support “Contributing to Decarbonized Societies” and “Promoting Stable, Sustainable Societies and Lifestyles.”Inquiry RecipientMitsubishi CorporationTelephone:+81-3-3210-2171 Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
Blokade AS mengancam ‘kejatuhan kemanusiaan’ di Cuba – Ketua PBB kewangan

Blokade AS mengancam ‘kejatuhan kemanusiaan’ di Cuba – Ketua PBB

February 5, 2026
(SeaPRwire) - Setiausaha Agung Antonio Guterres telah menyifatkan keadaan di pulau itu “sangat membimbangkan” Setiausaha Agung PBB Antonio Guterres telah memberi amaran bahawa sekatan tenaga yang dikenakan oleh AS boleh menyebabkan keruntuhan kemanusiaan di Cuba. Pihak berkuasa Cuba telah bersedia untuk melaksanakan rancangan pengagihan terhad untuk menangani kekurangan bahan api yang semakin teruk selepas Presiden AS Donald Trump mengancam untuk mengenakan tarif ke atas barangan daripada negara-negara yang menghantar minyak ke pulau itu. Presiden Cuba Miguel Diaz-Canel berkata sekatan itu telah menyebabkan pemadaman elektrik dan mengganggu sekolah-sekolah, hospital-hospital, dan pengangkutan awam. Pada taklimat khas pada hari Khamis, jurucakap PBB Stephane Dujarric berkata Guterres “sangat bimbang tentang keadaan kemanusiaan di Cuba, yang akan menjadi lebih teruk, jika tidak runtuh, jika keperluan minyaknya tidak dipenuhi.” Menurut Dujarric, Guterres menyatakan bahawa Perhimpunan Agung PBB “sentiasa menyeru untuk menamatkan embargo yang dikenakan oleh Amerika Syarikat ke atas Cuba.” AS telah mengekalkan embargo perdagangan terhadap Cuba sejak 1960. Pada Disember 2025, Tentera Laut AS dan Pengawal Pantai AS mula menyita kapal tangki di Laut Caribbean kerana didakwa melanggar sanksi. Trump menuduh Cuba menyokong kumpulan pengganas dan menggambarkan hubungan Havana dengan Rusia, China, dan Iran sebagai ancaman kepada keselamatan negara AS. Pada Khamis, AS mengumumkan ia akan menghantar bantuan tambahan $6 juta kepada Cuba, kebanyakannya untuk kawasan timur pulau yang dilanda Taufan Melissa tahun lepas. Jeremy Lewin, pegawai kanan Jabatan Negara yang bertanggungjawab terhadap bantuan kemanusiaan, menuduh kerajaan Cuba menyimpan sumber dan menafikan bahawa kekurangan makanan dikaitkan dengan larangan penghantaran minyak. Dalam ucapan pada Khamis, Diaz-Canel menolak dakwaan bahawa Cuba menyokong keganasan atau menimbulkan ancaman kepada AS. Beliau berkata kerajaan bersedia untuk dialah usaha dengan Washington, tetapi hanya berdasarkan persamaan dan penghormatan kepada kedaulatan Cuba.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan JCN Newswire

Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan

February 5, 2026
TOKYO and SHANGHAI, Feb 6, 2026 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Shanghai Henlius Biotech, Inc. (Headquarters: Shanghai, China, CEO: Jason Zhu, “Henlius”) announced today the conclusion of an exclusive commercialization and co-exclusive development and manufacturing license agreement for the anti-PD-1 antibody serplulimab (generic name, marketed as HANSIZHUANG in China and Hetronifly® in the EU) in Japan.Serplulimab, a novel anti-PD-1 monoclonal antibody developed by Henlius, is reported to possess a unique binding mode that differs from existing anti-PD-1 antibodies. 1 In China, it has been approved for indications such as squamous non-small cell lung cancer (sqNSCLC), extensive-stage small cell lung cancer (ES-SCLC), non-squamous non-small cell lung cancer (nsNSCLC), and esophageal squamous cell carcinoma (ESCC). In the EU, it has been approved for ES-SCLC. It is the world's first anti-PD-1 antibody to be used as a first-line treatment for ES-SCLC.In Japan, Henlius is currently conducting a Phase II bridging clinical trial for ES-SCLC, and plans to submit an application for fiscal year 2026 based on the results of this trial as well as the Phase III clinical trial data that supported approvals for this indication in China and Europe. Furthermore, a Phase III multi-national clinical trial for non-high-frequency microsatellite instability (non-MSI-High) metastatic colorectal cancer is underway, with development for new indications also planned.In Japan, it is estimated that there are approximately 13,000 patients diagnosed with ES-SCLC and about 28,000 patients diagnosed with non-MSI-High metastatic colorectal cancer, both of which are considered to have high unmet medical needs. 2,3,4,5Under the terms of this agreement, Eisai will obtain exclusive rights to commercialize serplulimab in Japan. In addition to ES-SCLC and non-MSI-High metastatic colorectal cancer, Henlius plans to also conduct a clinical trial for perioperative gastric cancer in Japan, and will assume the responsibilities of the Marketing Authorization Holder.Eisai will pay Henlius a contractual upfront payment of USD 75 million (approximately JPY 11.6 billion*), in addition to regulatory milestone payments of up to USD 80.01 million (approximately JPY 12.4 billion), and sales milestone payments of up to USD 233.3 million (approximately JPY 36.2 billion). Furthermore, Eisai will pay double-digit royalties based on sales of the product. Eisai anticipates no changes to its consolidated financial forecast for the period ending March 31, 2026.“We are pleased to collaborate with Eisai in Japan to advance the development of serplulimab in this important market,” said Dr. Jason Zhu, CEO of Henlius. “Serplulimab has demonstrated its potential across multiple tumor types through global clinical development and regulatory approvals, and Japan represents a critical step in its international journey. By combining Henlius’ innovation capabilities with Eisai’s deep local expertise, we aim to support the efficient development of serplulimab and address unmet medical needs for patients in Japan.”“Serplulimab is an anti-PD-1 monoclonal antibody that has been developed with high priority for indications with significant unmet medical needs, including ES-SCLC, and has already obtained approval for multiple indications in China and the EU. We anticipate that it will also become a promising treatment option in Japan for ES-SCLC and non-MSI-high metastatic colorectal cancer, for which development is underway, as well as for other intractable cancers,” said Toshihiko Yusa, Executive Officer and Head of Japan Business at Eisai. “Eisai will make every effort, in cooperation with Henlius, to deliver serplulimab to patients as soon as possible.”* Converted at an exchange rate of USD 1 = JPY 155MEDIA CONTACTSEisai Co., Ltd. Public Relations DepartmentTEL: +81 (0)3-3817-5120Shanghai Henlius Biotech Inc.Janice Hanjiayi_han@henlius.comBella Zhouwenting_zhou@henlius.comINVESTOR CONTACTSEisai Co., Ltd.Investor Relations DepartmentTEL: +81 (0) 3-3817-5122Shanghai Henlius Biotech Inc.Venus Hu junyan_Hu@henlius.com About SerplulimabSerplulimab (generic name, marketed as HANSIZHUANG in China and Hetronifly® in the EU) is an anti-PD-1 monoclonal antibody first developed by Shanghai Henlius Biotech, Inc. (“Henlius”), and launched in China in 2022. It has been approved by the National Medical Products Administration of China for indications including squamous non-small cell lung cancer, extensive-stage small cell lung cancer (ES-SCLC), esophageal squamous cell carcinoma, and non-squamous non-small cell lung cancer, and is the world's first anti-PD-1 antibody to be used as a first-line treatment for ESSCLC. It has been approved for the treatment of ES-SCLC in over 40 markets, including the EU, Southeast Asia (Indonesia, Cambodia, Thailand, Singapore, Malaysia), and South America (Peru). Henlius is actively promoting the broader use of serplulimab both as a standalone product and in combination with other innovative therapies, including those developed in-house and externally. Furthermore, the company is conducting numerous clinical trials worldwide on therapies for conditions where existing anti-PD-1 antibodies have not yet been used, focusing on indications such as lung cancer and gastrointestinal tumors.About Eisai Co., Ltd.Eisai's Corporate Concept is "to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), by working on various activities together with global partners.For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai Co., Ltd.), and connect with us on X, LinkedIn and Facebook. The website and social media channels are intended for audiences outside of the UK and Europe.About Shanghai Henlius Biotech, Inc.Shanghai Henlius Biotech, Inc. (2696.HK) is a global, innovation-driven biopharmaceutical company committed to delivering high-quality, affordable biologic therapies to patients worldwide. The Company focuses on major disease areas including oncology, autoimmune diseases, and ophthalmic diseases. Founded in 2010, Henlius has established an integrated, end-to-end biopharmaceutical platform encompassing global R&D, clinical operations, regulatory affairs, manufacturing, and commercialisation. The Company employs nearly 4,000 people globally and operates across multiple regions, including China, the United States, and Japan. Leveraging the stable cash flow generated from its biosimilar portfolio to support innovation, Henlius is steadily advancing into its “Globalisation 2.0” phase, building a scalable and sustainable global growth model. As of early 2026, Henlius has achieved regulatory approvals for 10 products across 60 countries and regions worldwide, including seven approvals in China. The Company has also reached multiple milestones in major biopharmaceutical markets, with four products approved by the U.S. Food and Drug Administration (FDA) and four products authorized by the European Medicines Agency (EMA), reflecting its globally aligned R&D capabilities, quality systems, and manufacturing standards.Driven by innovation, Henlius has built a diversified, platform-based technology ecosystem through coordinated R&D efforts across Shanghai, the United States, and other regions. Its innovation platforms span immune checkpoint inhibitors, immune cell engager technologies (including multispecific T cell engagers), antibody-drug conjugates (ADCs), and AI-enabled early discovery platforms. The Company currently has more than 50 early-stage innovative assets, approximately 70% of which are expected to be best-in-class, with over 30 clinical trials ongoing globally. Henlius’ core product, serplulimab (trade name: Hetronifly® in Europe), is the world’s first anti–PD-1 mAb approved for first-line treatment of small cell lung cancer and has been approved in more than 40 markets worldwide with an accelerated globalisation process. In parallel, multiple high-potential innovative assets—including the PD-L1 ADC HLX43 and the novel epitope anti-HER2 mAb HLX22—are advancing through global pivotal clinical development. Supported by a biologics manufacturing network with a total capacity of 84,000L and GMP certifications from regulatory authorities in China, Europe, and the United States, Henlius has established a stable global supply system serving six continents. Guided by a patient-centred mission, Henlius remains focused on addressing unmet medical needs and translating scientific innovation into meaningful clinical value and patient access, contributing sustainably to the global biopharmaceutical ecosystem.To learn more about Henlius, visit https://www.henlius.com/en/index.html and connect with us on LinkedIn at https://www.linkedin.com/company/henlius/.References1. Issafras H, Fan S, Tseng C-L, Cheng Y, Lin P, Xiao L, et al. (2021) Structural basis of HLX10 PD1 receptor recognition, a promising anti-PD-1 antibody clinical candidate for cancer immunotherapy. PLoS ONE 16(12): e0257972. https://doi.org/10.1371/journal.pone.02579722. National Cancer Center Japan, Cancer Information Service, Cancer Statistics (Japanese only) https://ganjoho.jp/reg_stat/statistics/stat/cancer/index.html Last accessed: January 2026.3. Sabari, J., Lok, B., Laird, J. et al. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol 14, 549–561 (2017).4. Fujiyoshi K, Yamamoto G, Takenoya T et al. Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor. Anticancer Res. 2017;37(1):239- 247.5. Cancer Statistics in Japan-2025 https://www.fpcr.or.jp/pdf/pamphlet/cancer_statistics_2025.pdf (P30) Last accessed: January 2026. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
Fujitsu Japan and JMDC announce collaboration to build sustainable healthcare system in Japan through enhanced medical data utilization JCN Newswire

Fujitsu Japan and JMDC announce collaboration to build sustainable healthcare system in Japan through enhanced medical data utilization

February 5, 2026
Kawasaki and Tokyo, Japan, Feb 6, 2026 - (JCN Newswire via SeaPRwire.com) - Fujitsu Japan Limited and JMDC Inc. today announced the commencement of a collaboration aimed at advancing medical care and contributing to the establishment of a sustainable healthcare system in Japan.This collaboration, which began on January 5, leverages JMDC's expertise in utilizing anonymized medical data and Fujitsu Japan's customer base. Fujitsu Japan holds the top share in the Japanese electronic health record (EHR) market for medical institutions. This synergy will accelerate the utilization of medical data by medical institutions and organizations that are part of the healthcare system, while also supporting data-driven management decision-making.This collaboration will see the two companies combine Fujitsu Japan's knowledge in the medical field and advanced technologies including AI, with JMDC's prediction models based on insurance user data and its expertise cultivated through Pep Up, one of Japan's largest personal health record services used by 7.7 million people. This will expand the scope of data utilization from DPC data [1] to comprehensive EHR data. This initiative will further promote the utilization of medical data, contributing to improved management for medical institutions and advanced research for pharmaceutical companies, government agencies, and academia.Going forward, Fujitsu Japan will contribute to the realization of digital hospitals that promote DX in medical institutions, while JMDC will advance initiatives that contribute to "building a sustainable healthcare system through addressing social issues with the power of data and ICT" and "accelerating the societal integration of data."Overview of the collaborationFujitsu Japan will provide Dashboard 360, a solution that enables visualization and analysis of management and clinical data, free of charge [2] to medical institutions that agree to provide anonymized DPC data [3]. Dashboard 360 is offered as part of Fujitsu Limited's Uvance business model, which addresses societal challenges, specifically within the Smart Hospital offering that maximizes hospital operational efficiency and effectiveness. It is a component of the Healthcare Management Platform, a suite of services designed to optimize patient flow [4] in acute care hospitals and support the resolution of management challenges.Dashboard 360 seamlessly integrates with EHRs, allowing for factor analysis of issues such as declining bed occupancy rates and waiting times for hospitalization or surgery, based on information including inpatient care and outpatient conditions leading to hospitalization. It also features a benchmarking function, utilizing data provided by JMDC and DPC data from medical institutions, to support timely decision-making in hospital management.JMDC will collaborate with Fujitsu Japan to anonymize DPC data in a secure environment and provide it to pharmaceutical companies, government agencies, and universities for research purposes. Additionally, by combining this with JMDC's accumulated insurance user data, covering approximately 20 million individuals, the collaboration will visualize the entire patient journey from pre-onset abnormal test results to inpatient treatment and post-discharge prognosis. This will enable early detection of diseases through screening of potential patients, prevention of severe cases by identifying risk factors, and precise evaluation of long-term treatment effects and drug safety in real-world settings, thereby contributing to the improvement of medical quality and efficiency.Figure: Collaboration overviewBackgroundIn Japan, the aging population and increasing medical expenses are pressing concerns. Challenges such as a shortage of healthcare professionals and financial difficulties for medical institutions persist. By leveraging medical data, it is expected that these challenges can be addressed through improved diagnostic accuracy, enhanced operational efficiency, development of new treatment methods, and strengthened regional healthcare collaboration.[1] DPC data:Data used to calculate medical costs based on the patient's diagnosis and treatment content during hospitalization. It includes patient information, diagnoses, surgical procedures, medications used, and is expected to be utilized for analyzing medical quality and hospital management, as well as for formulating healthcare policies.[2] Agreement to provide anonymized DPC data:Fujitsu Japan is entrusted by medical institutions with the creation of anonymized information such as DPC data, and the medical institutions grant Fujitsu Japan permission for secondary use of the created anonymized information.[3] Free of charge:No initial setup or usage fees. A separate license fee for the BI tool included in the service is required.[4] Patient flow:The management of the entire patient process from hospital visit to discharge.About FujitsuFujitsu's purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuAbout JMDCEstablished in 2002 as a pioneer in the medical big data industry, JMDC possesses proprietary anonymization processing technology and data analysis/aggregation technology. Based on the analysis of over 1.573 billion medical claims data and over 76 million health checkup data (as of March 2025), JMDC provide information services, including support for health promotion programs for payers, drug safety evaluation, and healthcare economics analysis. JMDC is committed to realizing a healthy society through medical data and analytical capabilities, providing a single index for health (Health Age) and web services for health promotion (Pep Up), among others. Find out more: https://www.jmdc.co.jp/en/Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiriesJMDC Inc.JMDC Inc. IR OfficeEmail: jmdc-pr@jmdc.co.jp Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
Genesys and Fujitsu Transform AEON Financial Service’s Contact Center Operations with Genesys Cloud Delivers Customers an Improved Self-Service Experience Resulting in Higher Completion and Reduced Wait Times JCN Newswire

Genesys and Fujitsu Transform AEON Financial Service’s Contact Center Operations with Genesys Cloud Delivers Customers an Improved Self-Service Experience Resulting in Higher Completion and Reduced Wait Times

February 5, 2026
Tokyo and Kawasaki, Japan, Feb 6, 2026 - (JCN Newswire via SeaPRwire.com) - Genesys® Cloud Services, Inc. (Headquarters: Minato-ku, Tokyo; President: Paul Ito Ricci, hereinafter Genesys), a global cloud leader in AI-Powered Experience Orchestration, and Fujitsu Limited (Headquarters: Kawasaki City, Kanagawa Prefecture; President and CEO: Takahito Tokita; hereinafter Fujitsu) which led the implementation of Genesys Cloud, announced the successful transformation of AEON Financial Service Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; President and CEO: Tomoharu Fukayama; hereinafter AEON Financial Service) contact center operations and the completion of its effectiveness evaluation.As part of this contact center transformation initiative, AEON Financial Service deployed Genesys Cloud™, a unified experience orchestration platform. Because of the composability of the Genesys Cloud platform, Fujitsu implemented customizations to meet its unique business requirements, including reporting management and system integrations, and will continue to support maintenance and operations. With over 2,500 seats, this deployment is among the largest of its kind in Japan’s financial sector.AEON Financial Service plans to introduce an “AI Concierge (Voice Bot)” utilizing speech recognition technology. This will allow customers to be guided to the appropriate menu through natural spoken dialogue, eliminating the need for phone keypad input. Furthermore, AEON Financial Service is considering expanding the solution to other contact centers across the AEON Group. Genesys and Fujitsu will continue to support the advancement of contact center systems across the entire AEON Group.Paul Ito Ricci, President of Genesys Japan, commented:"AEON Financial Service is demonstrating how modern experience orchestration can transform customer engagement at scale in a short period.By moving its contact center platform to the cloud, the company has been able to internalize system development and significantly accelerate the speed at which it can deliver more convenient services to address customers’ needs. . We are committed to supporting AEON Financial Service through Genesys Cloud as they utilize AI to deliver innovative, personalized and empathic customer experiences and seamless support for each individual at scale."Masaru Yagi, Executive Vice President, Fujitsu Limited, commented:"We are pleased to announce the successful introduction of Genesys Cloud to enhance the contact center operations for AEON Financial Service. This initiative addresses the crucial and growing need for contact center transformation in recent years. We are confident that this project meaningfully contributes to establishing an operator-first environment where high-quality customer experience can be delivered without added burden. Fujitsu will continue to support the implementation and operation of Genesys Cloud as a solution vendor, leveraging AI and other technologies to support AEON Financial Group and many other companies."BackgroundAEON Financial Service call center is responsible for comprehensive support across a wide array of financial services, including banking, insurance, and loans, in addition to payment services such as AEON Pay, AEON Card, and WAON. A significant challenge for the company was the increase in customer waiting times due to the growing variety of inquiry types and the increasing specialization and segmentation of internal guidance points. Moreover, the conventional on-premises call center system required modernization to effectively support future service expansion.Improvements driven by the contact center operations overhaulFollowing the deployment of Genesys Cloud and the overhaul of its contact center operations, AEON Financial Service has realized the following benefits within the first six months:1. Higher self-service completion ratesBy expanding self-service options within the IVR (Interactive Voice Response) system, the self-completion rate for the menu option that allows customers to report payments after a failed withdrawal improved by 21 percentage points compared to the previous system, helping reduce customer wait times.2. Automated SMS supportBy implementing a mechanism that automatically sends an SMS in response to IVR inquiries, simple questions can now be resolved through self-service. This allows operators to concentrate on more complex tasks.3. Rapid feature enhancements and flexible operationsThe use of a cloud service with the requirement of a low-code functionality enables the speedy deployment of new services and quick changes to the IVR structure. Furthermore, future efforts to bring development in-house will allow for even faster response times.About GenesysGenesys® empowers more than 8,000 organizations worldwide to create the best customer and employee experiences. With agentic AI at its core, Genesys Cloud™ is the AI-Powered Experience Orchestration platform that connects people, systems, data and AI across the enterprise. As a result, organizations can drive customer loyalty, growth and retention while increasing operational efficiency and teamwork across human and AI workforces. www.genesys.com/ja-jpAbout FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuPress ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiriesGenesys Cloud Services, Inc. Genesys PR Office (Initial Inc.)Contacts: Hirabayashi, Nagaoka, AkiyamaTel: +81-3-5572-7334 Email: genesys_pr@vectorinc.co.jp Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More

Model baru OpenAI melompat ke hadapan dalam keupayaan pengekodan—tetapi menimbulkan risiko keselamatan siber yang belum pernah berlaku sebelum ini

February 5, 2026
(SeaPRwire) - OpenAI percaya ia akhirnya telah mencapai keunggulan dalam salah satu perlumbaan yang paling diperhatikan dalam kecerdasan buatan: pengekodan yang dikuasakan AI. Model terbarunya, GPT-5.3-Codex, merupakan kemajuan yang kukuh berbanding sistem saingan, menunjukkan prestasi yang jauh lebih tinggi dalam penanda aras pengekodan dan hasil laporan berbanding generasi terdahulu daripada kedua-dua model OpenAI dan Anthropic—menunjukkan keunggulan yang telah lama dicari dalam kategori yang boleh membentuk semula cara perisian dibina. Tetapi syarikat itu melancarkan model ini dengan kawalan yang sangat ketat dan menunda akses penuh kepada pembangun semasa menghadapi realiti yang lebih sukar: keupayaan yang sama yang menjadikan GPT-5.3-Codex sangat berkesan dalam menulis, menguji, dan membuat penaakulan tentang kod juga menimbulkan kebimbangan keselamatan siber yang serius. Dalam perlumbaan untuk membina model pengekodan paling berkuasa, OpenAI telah terjun ke dalam risiko melancarkannya. GPT-5.3-Codex tersedia kepada pengguna ChatGPT berbayar, yang boleh menggunakan model ini untuk tugas pembangunan perisian harian seperti menulis, membetulkan ralat, dan menguji kod melalui alat Codex OpenAI dan antara muka ChatGPT. Tetapi buat masa ini, syarikat itu tidak membuka akses tanpa had untuk kegunaan keselamatan siber berisiko tinggi, dan OpenAI tidak serta-merta membolehkan akses API penuh yang membolehkan model diautomasi secara besar-besaran. Aplikasi yang lebih sensitif itu dikawal di belakang langkah perlindungan tambahan, termasuk program akses dipercayai baru untuk profesional keselamatan yang telah disemak, yang mencerminkan pandangan OpenAI bahawa model ini telah melepasi ambang risiko keselamatan siber baru. Kenyataan syarikat yang disertakan dengan pelancaran model pada Khamis berkata bahawa walaupun ia tidak mempunyai "bukti muktamad" model baru boleh mengautomasi serangan siber sepenuhnya, "kita mengambil pendekatan berjaga-jaga dan menggunakan rangkaian keselamatan siber yang paling komprehensif setakat ini. Langkah mitigasi kami termasuk latihan keselamatan, pemantauan automatik, akses dipercayai untuk keupayaan lanjutan, dan pipeline penguatkuasaan termasuk maklumat ancaman." CEO OpenAI, Sam Altman, menulis dalam mengenai kebimbangan itu, mengatakan bahawa GPT-5.3-Codex ialah "model pertama kami yang mencapai 'tinggi' untuk keselamatan siber dalam rangka kerja kesiapsiagaan kami," sebuah sistem klasifikasi risiko dalaman yang digunakan OpenAI untuk pelancaran model. Dalam erti kata lain, ini ialah model pertama yang dipercayai OpenAI cukup baik dalam pengekodan dan penaakulan sehingga ia boleh membolehkan bahaya siber dunia sebenar secara bermakna, terutamanya jika diautomasi atau digunakan secara besar-besaran. Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More